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Abstract 
A thorough microdosimetric investigation of a p(66)/Be( 40) neutron therapy beam 
has been performed with a tissue equivalent proportional counter. The measured 
lineal energy spectra and derived averages were observed to change for different 
irradiation conditions pertinent to therapy. Using the parameter y* as an indicator 
of radiation quality, variations in the potency of the beam were quantified with 
spatial position and field size in a water phantom, and in the dose build-up region 
measured in-air. To accommodate these quality changes in the prescription of 
absorbed dose, the concept of effective dose is invoked to show that if unaccounted 
for, the quality changes with depth alone would result in a 4% discrepancy between 
the prescribed and effective dose delivered to the tumour volume. The implications 
for optimum dose delivery in clinical practice are discussed in terms of these findings. 
The timing characteristics of commercial Rossi-type proportional counters operating 
at low gas pressures were studied in a pulsed neutron beam of nominal energy 
63 MeV. The correlation between electron drift and counter dimensions is 
demonstrated from TOF measurements performed in normal and helix modes. By 
identifying each registered pulse height event with its own time--0f-flight, it is shown 
that the timing response is masked by amplitude walk derived in the time pick--0ff. 
The inherent response of the counter in helix mode (FWHM < 6 ns) is revealed after 
accounting for time slewing and compares favourably with that of an NE213 liquid 
scintillator (FWHM = 3.8 ns ). Distinct structure associated with the incident energy 
spectrum is discernible and enables the unambiguous selection of energy deposition 
events resulting from neutrons of the nominal energy. 
Time-<'.orrelated microdose spectra were measured with the tissue equivalent and 
carbon proportional counters in three different quasi-monoenergetic neutron fields 
with nominal peak energies of 26, 42 and 63 MeV. The time gated spectra are the 
first reported microdose distributions for truly monoenergetic neutrons in this energy 
range. The gas-to-wall dose conversion factor for the TE gas filled carbon counter 
was evaluated from the data so obtained and appeared to increase over the energy 
range investigated. Subsequently the kerma ratio of carbon to A-150 plastic was 
determined at each of the three energies and the results found to concur with other 
published data using different techniques. 
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CHAPTER 1 
INTRODUCTION 
This thesis describes experimental investigations which provide qualitative and 
quantitative information relating to fast neutron beams. The dosimetry data 
described can be applied to neutron therapy beams to ensure that this new modality 
is used to the best possible advantage in the treatment of malignant disease. 
Prospective clinical trials are currently underway at Faure, South Africa to determine 
whether the radiobiological promise offered by fast neutrons can be realised in routine 
radiotherapy. This necessitates a direct comparison between the clinical effects of 
neutron and conventional photon treatments. To provide a valid comparison it is 
essential that the different modalities be similarly optimised in terms of both physical 
characteristics and accuracy of dosimetry. 
History of neutron therapy 
The first attempt at treating cancers with accelerator-produced beams of fast 
neutrons was initiated in 1938, only six years after James Chadwick's identification of 
the particle. At the time there was no scientific rationale for their use other than it 
was hoped that relative to their effects on normal tissues, neutrons would be more 
effective than X or ,-rays in controlling malignant tumour growth. This pioneering 
work was to end during the Second World War when the Berkeley cyclotron in 
California was needed for the war effort. Although a few of the patients were still 
alive some 30 years later, a great deal of harm was done because of excessive normal 
tissue damage. It was recommended by the principal investigator, Stone, in his 
Janeway lecture of 1947 (Stone, 1948) that there was no justification for the 
2 
continuance of neutron therapy. Not until 1966 was neutron therapy again attempted 
when the group at Hammersmith Hospital in Britain commenced their studies. In 
the intervening years a rationale for neutrons had formed on the basis of a number of 
radiobiological experiments. Appreciation was made of what were then considered 
the most important factors such as the decrease in the oxygen enhancement ratio 
(OER) when neutrons are used instead of X-rays, and changes in the relative 
biological efficiency (RBE) with fractionation and dose level. The Hammersmith 
group started to achieve encouraging results (Catterall, 1974a and b) which the 
medical community were all too ready to sieze upon. Based upon the Hammersmith 
findings, facilities throughout the world launched clinical programmes. 
Of necessity these centres were often founded at already existing accelerators not 
designed for medical purposes and at sites which were not hospital based. The 
machines themselves produced only low energy (En < 10 MeV) neutrons with poor 
penetrating power and inflexible beam delivery systems. The importance of these 
inadequacies were not fully appreciated at the time since it was believed the benefit 
in local control and long term survival would outweigh the physical disadvantages. 
Conflicting results started to emerge and serious doubts about the efficacy of fast 
neutrons compared to conventional modalities were again raised (Duncan et al., 1984 
and 1985). Gradually it was realised that the outcome of these early trials was being 
masked by the use of sub-optimal neutron beams and that a fair and proper 
comparison was still sought. Neutron therapy centres were needed which were 
similar in all aspects to isocentric megavoltage electron accelerators producing 
penetrating low scatter bremsstrahlung photon beams so that all physical differences 
could be eliminated. In this way the biological properties of the two modalities could 
be compared unequivocally. Such proposed facilities are technically advanced and 
costly. This placed reliance upon funds coming from national bodies with a 
natural reluctance for different countries to operate more than one neutron 
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therapy centre at a time. The result today is that only a few modern neutron therapy 
units have been constructed world-wide as shown in Table 1.1 which lists all the 
currently operational centres with their respective design attributes. 
Table 1.1 Operational neutron therapy facilities {Modified from Wambersie, 
1990 and Budach, 1991) 
NEUTRON THERAPY FACILITIES 
Centre 
Ev.rope 
Clatterbridge, UK 
Orleans, France 
Nice, France 
Louvain-la-Neuve, Belgium 
Hamburg, Fed.Rep.Germany 
Heidelberg, Fed. Rep. Germany 
Munster, Fed. Rep. Germany 
Essen, Fed. Rep. Germany 
USA 
Houston, Texas 
Seattle, Washington 
Batavia, Illinois 
Detroit, Michigan 
Asia 
Chiba, Japan 
Tokyo, Japan 
Seoul, Korea 
Riyadh, Saudi Arabia 
Africa 
Faure, South Africa 
Neutron Reaction 
p(62)/Be 
p(34)/Be 
p(65)/Be 
p(65)/Be 
(d + T) 
(d + T) 
(d + T) 
d(14)/Be 
p( 42)/Be 
p(50)/Be 
p(66)/Be 
d(50)/Be 
d(30)/Be 
d(14)/Be 
d(51)/Be 
p(26)/Be 
p(66)/Be 
Comments 
Isocentric Gantry 
Variable Collimator 
Vertical Beam 
Vertical Beam 
Multileaf Collimator 
Vert. + Hor. Beam 
Multileaf Collimator 
Isocentric Gantry 
Isocentric Gantry 
Isocentric Gantry 
Isocentric Gantry 
Isocentric Gantry 
Variable Collimator 
Isocentric gantry 
Multileaf Collimator 
Horizontal Beam 
Isocentric Gantry 
Superconducting Cyclo-
tron 
Vertical Beam 
Multileaf Collimator 
Horizontal Beam 
Isocen tric Gan try 
Isocentric Gantry 
Isocentric Gantry 
Variable Collimator 
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One such facility complying with all the envisaged requirements is the newly 
completed National Accelerator Centre (N AC) at Faure. Here a reliable source of 
high intensity fast neutrons is produced by 66 Me V protons impinging on a semi-thick 
(non-stopping) beryllium target (Jones et al., 1988). Full isocentric capabilities and 
a variable collimator ensure flexible beam delivery. The facility has a small hospital 
attached with radiotherapists participating from two large teaching hospitals situated 
nearby. Reliable operation of the accelerator ensures the minimum of interruptions 
to treatment schedules and all physical conditions have been optimized. Under such 
circumstances direct comparisons between neutrons and photons can earnestly begin. 
Variations in beam quality 
Many sources of uncertainty exist in radiotherapy procedures (Svensson, 1984) and 
these need careful consideration so as not to jeopardise the final outcome of a 
proposed trial. Potentially significant are uncertainties arising in clinical dosimetry 
and in particular the expression of absorbed dose merits special attention. Ideally the 
purpose of defining a dose in radiation therapy is to provide a physical quantity that 
will ensure the desired clinical response in the irradiated tissue. In neutron 
dosimetry, however, the singular specification of absorbed dose cannot uniquely 
quantify the therapy beam since radiation of different types or of the same type but 
of different energies can, for equal absorbed doses, produce different degrees of 
damage as measured by a specific biological endpoint. In recognition of this 
phenomenon the term radiation quality is used to empirically quantify the 
effectiveness of different radiation types. Radiotherapists are acutely aware of the 
need for greater accuracy in the delivery of absorbed dose to the target volume in 
order to maximise tumour control with the minimum of complications to normal 
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tissue. To assist in arnvmg at the appropriate prescribed dose when treating the 
same tumour type at different therapy centres, cognizance is taken of differences in 
beam quality. Collective experience has led to the so--<:alled Clinical Neutron 
Inter comparison Factor ( CNIF) which converts the physical expression of dose into 
an effective or biological dose which is more relevant to clinical practice (Wambersie 
and Battermann, 1987). This approach is a necessary pragmatic solution to the very 
real problem of relating clinical experience in one neutron beam of a particular 
radiation quality to another so as to optimise treatment regimens. What these 
factors do not incorporate, however, is any allowance for potential variations in RBE 
within the patient. 
To identify irradiation conditions which might bring about variations m neutron 
beam quality is very necessary and requires a systematic study. Experimental 
microdosimetry with tissue equivalent proportional counters (TEPCs) is highly suited 
for this purpose as it provides physical data that have previously proved a reliable 
indicator of quality changes between different neutron therapy beams (Menzel, 1984). 
Absorbed dose determinations 
As long as clinical experience in the treatment of a certain type of tumour remains 
restricted to a particular centre and to one radiation quality, only the reproducibility 
in the absorbed dose delivered to the patient during radiotherapy is pertinent. 
Prospective neutron trials by their very nature are, however, comparisons of different 
types of radiations usually involving a neutron centre and at least one other referral 
hospital. In this instance the overall uncertainty in the actual dose absorbed becomes 
important. For irradiation prescriptions to be equivalent and thus comparable, the 
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accuracy in the absorbed doses administered for each modality needs to be the same 
and within certain specified bounds. These limits were quantified in an earlier review 
(Mijnheer et al., 1987a) and show that the overall uncertainty in the dose estimation 
for high energy neutrons is approximately 8%, nearly twice that of their conventional 
counterparts. The single largest contributor to this error derives from the 
determination of absorbed dose at a reference point in a phantom which is usually 
deduced from measurements performed with gas filled ionization chambers. To 
convert the charge produced within these chambers to absorbed dose in tissue 
requires knowledge of a number of energy dependent parameters. The two with the 
largest associated uncertainties are W, the mean energy required to create an ion pair 
in the gas filling and KT/K AlSO' the ratio of neutron kerma factors for tissue and 
A-150 plastic, the material from which the wall of the ionization chamber is made. 
The neutron kerma factor for a particular material or element is the kerma per unit 
neutron fluence and values are needed that extend over the entire energy range now 
embraced by neutron therapy. Kerma factors require an assessment of kerma which 
for A-150 plastic can in principle be measured directly. This is not possible for tissue 
and instead the result has to be synthesised from data for the elemental constituents. 
Kerma factors can be readily estimated for energies below 20 Me V where microscopic 
cross section information for the elements of interest are well known (Caswell et al., 
1988). At higher energies however, calculations become unreliable due to 
uncertainties in the nuclear cross section data required as input. As energies increase 
the problem is exacerbated by the opening up of more reaction channels, the 
probabilities of which are unknown. The measurement of kerma factors in the energy 
range 20 - 65 MeV is to be preferred but to date very few results are available 
(Romero et al., 1985; Schuhmacher et al., 1992; Schrewe et al., 1992a). Experimental 
determination of kerma for monoenergetic neutrons in this energy range is needed for 
better estimates of kerma factors. 
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Low pressure proportional counters have proved very successful in measuring the 
absorbed dose at the point of maximum build-up from which the kerma can be 
inferred. Previous measurements have been performed in almost pure monoenergetic 
neutron fields (En < 20 MeV) where there were few low energy contaminants. For 
energies above 20 MeV it is not possible to generate such monochromatic or "clean" 
beams as neutrons of the nominal energy are usually accompanied by a significant 
number of lower energy neutrons that result from nuclear excitation and break-up 
reactions with the target nuclei. Events from these low energy neutrons will be 
registered by the counter and an additional kerma not associated with neutrons of the 
nominal energy will be included in the measured response. This spurious kerma can 
constitute a large proportion of the measured kerma and corrections become 
necessary. 
An alternative approach is to apply time--0f-flight (TOF) techniques where event 
registration is dependent upon the neutron time of arrival at the detector. In this 
way it is possible to discriminate against the unwanted events due to slower, low 
energy neutrons. Unfortunately commercial proportional counters typically used in 
neutron dosimetry exhibit poor timing characteristics, making TOF determinations 
impractical because of the long flight paths and the intense radiation source that this 
would require. If the timing characteristics could be improved and reliable single 
event distributions obtained for neutrons of the nominal energy, then accurate kerma 
assessments in the energy range 20-65 MeV would be possible. 
Present study 
This work reports on experimental investigations into changes in radiation quality for 
a neutron therapy beam. In addition neutron kerma assessments in quasi-
monoenergetic beams utilizing the TO F technique are presented. Commercially 
available low pressure proportional counters are used throughout. 
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Initially a brief outline of microdosimetry concepts and practice followed by a 
description of the irradiation facilities available at the National Accelerator Centre 
are given. In Chapter 4 a thorough survey of a p(66)/Be( 40) therapy beam is 
presented and variations m beam quality identified using conventional 
microdosimetric techniques. To accommodate these quality changes in the 
prescription of absorbed dose, the concept of effective dose is invoked and elementary 
expressions are proposed to assess this quantity. The implications for optimum dose 
delivery in clinical practice are discussed in a separate chapter by incorporating the 
noted variations into a four field treatment plan. 
Chapter 6 will focus on time-resolved microdosimetry in a high energy 
quasi-monoenergetic field of nominal neutron energy 63 MeV. Reliable microdose 
distributions are measured when restricting the size of the sensitive volume of the 
detector. By applying standard TOF techniques a greatly improved timing response 
is obtained which compares favourably with that of an NE213 liquid scintillator. 
Distinct structure associated with the incident energy spectrum is discernible and 
enables the unambiguous selection of energy deposition events resulting from 
neutrons of the nominal energy. This method is applied in Chapter 7 to directly 
assess the total kerma associated with neutrons of a particular energy and additional 
measurements were performed at two different energies (En = 25.5 and 42.0 MeV) 
with both A-150 plastic and carbon proportional counters. Comparison of 
monoenergetic microdose spectra facilitated evaluation of r , the gas-to-wall dose 
m,g 
conversion factor for a TE gas filled carbon counter, and the kerma ratio of carbon to 
A-150 plastic. The work presented in the thesis is concluded with a summary. 
CHAPTER2 
ENERGY DEPOSITION - CONCEPTS AND PRACTICE 
Introduction 
During neutron irradiation of tissue energy transfers occur via nuclear interactions 
with nuclei of the constituent atoms (i.e. hydrogen, carbon, nitrogen and oxygen) 
resulting in various species of charged particles being set in motion. Depending on 
the energy of the incident neutron, different interactions with varying probabilities 
take place influencing the character of the produced secondary charged particle 
spectrum and this determines the concentrations of energy deposition in the medium. 
Although containing only 10.2% hydrogen by weight, the preponderance of hydrogen 
nuclei in tissue ( approximate atomic composition C5H400 18N) is significant in the 
energy transfer process. Elastic scattering off hydrogen is the dominant interaction 
as the incident particle (neutron) and target nucleus (proton) are of nearly equal 
mass enabling complete transfer of the incident kinetic energy in a head-on collision. 
Hydrogen also plays an important role in producing 2.2 MeV ,-rays by the capture 
of low energy neutrons that have attained thermal equilibrium with the irradiated 
tissue following successive collisions. This is one of the main sources of I radiation in 
patients and phantoms irradiated with neutrons. 
At higher neutron energies (En > 10 MeV) inelastic and non elastic reaction channels 
become possible and start contributing noticeably to the charged particle spectrum. 
These processes usually have energy thresholds in the range 4-12 MeV for the 
elements of interest with the reaction cross sections rising sharply as the threshold 
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energy is exceeded and levelling off at about 30 MeV. The relative kerma 
contributions for neutron energies up to 30 MeV are depicted in Figure 2.1 and a 
summary of the most important neutron interactions in tissue for energies up to 
approximately 100 Me V are listed in Table 2.1. 
Figure 2.1 
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processes with different elements (from ICR U, 1977). 
Irrespective of the nature of these interaction processes, energy transfer to the 
medium is ultimately expressed in terms of excitation and ionization of the 
constituent atoms and should not be considered as a single occurrence but rather as a 
series of random interactions interspersed at different locations within the medium. 
The amount of energy deposited in tissue is termed the absorbed dose which, as a 
single parameter, fails to predict biological response. Attempts to comprehend 
mechanisms that cause the observed biological damage require instead that the 
initiator of the action be defined over an appropriate scale. Knowledge of the 
ionization track density and the energy concentrations resulting from the charged 
particle spectrum become essential because it is these that determine the ability 
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Table 2.1 Summary of the most important neutron interactions in tissue for 
energies up to approximately 100 MeV (ICRU, 1977). 
Element Interaction 
Hydrogen 
Carbon 
Nitrogen 
Oxygen 
Elastic scattering 
Neutron capture 
Elastic scattering 
Inelastic scattering 
(n,n 1 3 a), (n, o:) and ( n,p) reactions 
Elastic scattering 
Inelastic scattering 
(n,p), (n,d), (n,t), (n,O:), (n,20:) and (n,2n) 
reactions 
Elastic scattering 
Inelastic scattering 
(n,O:) and (n,p) reactions 
of a particular radiation to inflict irreparable cell damage. Microdosimetry is a study 
of the character of these energy distributions in volumes approaching the size of a 
mammalian cell. 
Absorbed dose 
The absorbed dose is defined as 
D = liE (Gy) 
lim 
where liE is the mean energy imparted (in Joules) by ionizing radiation to matter in 
a volume element of mass lim (kilograms). The singular specification of absorbed 
dose does not however, uniquely quantify the effectiveness of the radiation as 
measured by a specific biological end-point. Whilst the observed biological damage 
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represents the aggregate response of the many cells that comprise the irradiated 
sample, the random nature of the energy deposition process creates a non-uniform 
distribution of energies imparted to the cells. As the response of a particular cell is 
dependent upon the energy it actually receives, it is this quantity and not the 
macroscopic averaged absorbed dose for the sample that is pertinent for describing 
the effectiveness of the radiation. 
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Figure 2.2 Energy density as a 
function of varying mass (from 
Rossi, 1968). 
This is best illustrated by considering for a given exposure variations in the ratio of 
E/m for an energy deposition E as the mass m of material confined to a finite volume 
is varied (Figure 2.2). The diagram may be divided into three regions of m, where 
the highest value of log mis associated with the recogllized density of the material. 
In region c the fluence of secondary charged particles is non uniform and attenuation 
of the indirectly ionizing radiation is observed, i.e. E/m dimillishes as m approaches 
its maximum value. In region b the particle fluence remains essentially uniform and 
conditions for Bragg-Gray cavity theory are satisfied, allowing for the macroscopic 
measurement of the absorbed dose D. By operating ionization chambers at ambient 
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gas pressures, the number of interactions is large enough to ensure that a statistically 
accurate value for the absorbed dose is estimated. If m is further reduced, the 
deposition of energy will depend on whether or not interactions occur with the 
material now sparsely dispersed throughout the volume (region a). Either no energy 
transfer occurs or a large amount of energy is transferred in a specific interaction or 
event, in which instance the ratio of E/m is termed the specific energy Z. Here 
energy is absorbed in an identifiable single event and the size of this event may vary 
over several orders of magnitude. 
A radiation source is characterized by the unique frequency distribution of event 
sizes, which when summed together give the absorbed dose. Differences in the 
effectiveness or quality of various radiation types, that is differences in the biological 
response to equal absorbed doses, relate to differences in the frequency and magnitude 
of local energy depositions that occur within the sensitive tissue volumes. As the 
discrete or quantised nature of the energy depositon processes only becomes apparent 
at microscopic mass levels, this necessitates that the resulting energy transfers be 
physically assessed on a scale of at least similar dimensions. 
Linear energy transfer 
The first attempts at specifying radiation quality in terms of a physical parameter led 
to the definition of linear energy transfer (LET). The LET or collision stopping 
power is defined as L = dE/dx where dE is the mean energy lost by a charged 
particle in collisions along an element dx of its trajectory. The LET takes into 
account all possible physical interaction processes and is applicable to all charged 
particles. The value of L depends upon the energy of the particle as shown in Figure 
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2.3. In the case of a mixed radiation field where there are particles of different 
charge, velocity and mass, a large range of L will be present. 
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Figure 2.3 Linear energy transfer for 
various secondary charged particles as 
a function of their energy ( reproduced from Bewley, 1989). 
To characterise a radiation field possessing a distribution of LETs by a single 
parameter requires that a mean value be determined. The frequency average LET 
(LF) and the absorbed dose average LET (10 ) can respectively be calculated as 
(ll (ll f L f(L) dL/ f f(L) dL (keV µm-1) 
0 0 
(ll (ll f L2f(L)dL/ f Lf(L)dL (keV µm-1) 
0 0 
where f(L) is the fraction of track lengths with LET between L and L + dL. These 
expectation values for the energy loss along linear tracks have been applied and 
proved adequate for selected phenomena, but were an over simplification of the 
fundamental processes as they did not recognise 
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(i) the finite range of charged particles 
(ii) lateral extension of the tracks ( energy dissipation by 8 rays) 
and (iii) energy loss straggling. 
In the case of protons for example, there are a wide range of site sizes for which the 
above are of little consequence and the LET concept can be applied without 
reservation (Kellerer and Chmelevsky, 197 5). These omissions cannot be ignored 
though for electrons where LET fails to properly describe the relevant microscopic 
properties of interest. 
LETandRBE 
In spite of these acknowledged shortcomings LET has been widely used as a physical 
description of radiation quality in biological systems. The relationship between the 
relative biological effectiveness (RBE) of a radiation source and the LET parameters 
that describe the radiation is, however, more complex than that of simple 
proportionality to either the frequency or dose averages. Experiments performed 
with tissue cultured mammalian cells yielded the non-linear LET vs. RBE 
relationship depicted in Figure 2.4 (Barendsen et al., 1963). It is evident from this 
data that the application of averaged LET values could lead to misguided 
conclusions. If for example, the LET distribution for a particular radiation type 
possesses sizable components above and below the peak shown in the curve, a lower 
RBE will be observed than that for a similarly centered narrow peaked distribution 
having the same average LET. 
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Figure 2.4 REE for 20% 
inactivation of cells in 
tissue culture as a funct-
ion of LET {reproduced 
from Barendsen et al., 
1963) 
In endeavouring to measure LET with low pressure proportional counters (Rossi and 
Rosenzweig, 1955a) it was realized the information from these detectors was superior 
to that originally sought, as it was the actual energy concentrations along the particle 
track rather than the finite energy loss of the particle that determined the noted 
biological effect. This led to new concepts and techniques which related energy 
absorption in low pressure proportional counters to energy depositions in subcellular 
volumes of micrometer dimensions. 
Lineal energy 
The concept of lineal energy measured for single events within the volume of a low 
pressure proportional counter provided a more relevant description of the energy 
imparted to matter. The lineal energy y is defined (ICRU, 1980) as 
y= E. (keV µm-t) 
where E. 1s the energy imparted by a single energy-deposition event within the 
17 
volume and l the mean chord length in that volume. The mean chord length is a 
geometrical parameter equivalent to the mean length of randomly orientated chords 
in the volume. For a convex body 
- 4V l=-
s 
where V is the volume and S the surface area of the body. In the case of an 
isotropically irradiated sphere of diameter d the mean chord length is 2/ 3 d. 
By definition lineal energy offers a method of evaluating the stochastic nature of 
multiple energy depositions. Two types of distributions account for the stochastic 
fluctuation in y; the probability distribution (or the normalised frequency 
distribution) which is the distribution of the fraction of the total number of events 
having event sizes between y and y+dy and is plotted as a function of y, and the 
normalised absorbed dose distribution which is the fraction of the total energy ( dose) 
that is deposited for event sizes between y and y+dy, plotted against y. Both 
distributions have expectation values that are direct analogues to the LET averages 
given earlier. The frequency mean y F reflects the average event size and under some 
restrictive conditions the dose mean y D provides a qualitative indication of biological 
effectiveness. The ratio yD/yF is a measure of the width or variance of the frequency 
distributions. These parameters refer only to energy depositions within a simulated 
site size of cellular dimensions and cannot be considered an adequate fundamental 
description of radiation quality. This is because they make no allowance for the other 
cells in the irradiated sample that receive no energy depositions at all but which also 
contribute to the aggregate biological response. 
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In recognition of the decrease in RBE observed for particles having an LET of more 
than about 100 ke V µm -1, an explanation involving excess energy concentrations in 
small site sizes was proposed. The assumption was made that on occasions of high 
local energy concentrations, more energy is deposited than required to produce the 
desired cellular effect and a saturation level is reached above which the deposition of 
additional energy produces no greater effect, and energy is consequently wasted. To 
accommodate this phenomenon the absorbed dose distribution is modified by an 
empirically derived weighting factor to provide the saturation corrected dose mean 
lineal energy y* given by 
y* 
with 
CD 
= J Y dsat(y) dy 
0 
y2 
0 
= - 2 (1 - exp - (y/y )2]d(y) y 0 
(keV µm-1) 
where y 
O 
1s a biologically determined saturation parameter (Kellerer and Rossi, 
1972). 
Although lineal energy distributions and averages provide quantitative data for a 
specific radiation field, a fundamental understanding of interaction with living cells is 
limited because there is no explicit relationship between the derived quantities and 
biological effect. Whilst there does not exist as yet any proven physical parameter of 
radiation that correlates closely and fundamentally with biological effect, the 
measurement of lineal energy distributions does have practical applications in the 
assessment of radiation quality. This has been demonstrated in the domains of 
radiation protection and therapy through an approximate empirical correlation with 
biological effectiveness over limited regions of practical interest. 
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Volume simulation 
Experimental microdosimetry using spherical proportional counters provides a means 
of assessing lineal energy probability distributions for simulated site sizes comparable 
to those of a mammalian cell i.e. 1-2 µm. These detectors have inherent signal 
amplification properties that enable the measurement of the full range of event sizes 
produced in the simulated volume and are sensitive enough to ensure good statistical 
accuracy for even small energy depositions. Technically it is not feasible to construct 
an energy spectrometer having dimensions of about 1 µm in condensed matter and 
instead a comparatively large volume detector is filled with a small mass of gas. 
To achieve the quantitative simulation of energy depositions in a small tissue volume, 
the energy loss experienced by a charged particle of a specific type (i.e. protons) and 
energy passing through the counter volume must be the same as that for a 
corresponding trajectory through the tissue volume, i.e. 
where S is the mass stopping power, p the density and x the path length, with 
subscripts g for the gas and t for tissue. If true tissue cqui valence is achieved for the 
gas, then the mass stopping powers for gas and tissue are considered equal and the 
microdosimetric quantities measured in the gas-filled counter will be scaled with 
respect to those occurring in the biological structure by the inverse ratio of their 
respective densities. 
Qualitatively the single event spectra measured with these counters are not identical 
to those in tissue due to differences in the elemental composition of A-150 plastic and 
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tissue and spurious phenomena termed wall effects (ICRU, 1983). The higher density 
of the counter walls can cause an increase in energy deposition within the gas cavity 
due to the inclusion of events which would otherwise occur in separate volumes in a 
medium of uniform density. The distortions introduced by wall effects are found to 
vary with the type and energy of the radiation (Kellerer, 1971). 
Principles of counter operation 
The geometry of a typical counter is either a spherical or cylindrical gas filled cavity 
with a sensitive volume that is delineated by a solid wall. A central wire electrically 
isolated from the wall material runs along the counter diameter or central axis. The 
counter wall is usually grounded. In traversing the cavity, the secondary charged 
particles ejected from the wall undergo energy losses through excitation and 
ionization of the gas filling and ion pairs are formed. If a voltage is applied between 
the conducting wall of the counter and the centre wire, the ion pairs are subjected to 
electric forces and a voltage change is induced at the centre wire or anode where the 
electrons are collected. The amount of charge collected is then a measure of the 
number of ion pairs produced in the counter gas and can be equated with the energy 
deposited in the cavity volume, provided the mean energy required to produce a 
single ion pair in the gas is known. This quantity, referred to as the W-value, is 
unique to the gas mixture and varies with the type and energy of the ionizing 
particle. 
The size of the pulse appearing at the centre wire depends on the applied voltage. If 
the voltage is high enough so that each primary ion acquires enough energy to 
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produce second and higher generation ions through collisions with the gas molecules 
(Townsend avalanche), an amplified pulse proportional to the deposited energy is 
produced. When an ionization chamber operates in this mode it is called a 
proportional counter (Knoll, 1979). The amplification or gas gain in a proportional 
counter is governed principally by the electric field strength across the sensitive 
volume and the pressure of the gas filling. In the simple case of a cylindrical counter 
the field strength at a radius r is given by 
V 
E (Vm-1) 
where V is the applied voltage and r 1 and r 2 are the radii of the centre wue and 
cylindrical cathode respectively. Usually gas amplification is restricted to a very 
small region close to the collecting wire and under these conditions the gas 
multiplication is nearly independent of the position from where the primary ion was 
produced. At very low gas pressures this multiplication region can extend further 
into the counter volume and the gain will depend upon the position of the event in 
the counter, thereby destroying the proportionality between energy deposited and 
pulse height. This places a lower limit (approximately 0.3 µm) on the possible site 
sizes which may be simulated with conventionally sized counters. 
Rossi-type proportional counter 
All measurements were performed with commercial "LET-1/2" proportional counters 
manufactured by Far West Technology (Goleta, USA). The counter design (Oliver et 
al., 1972) is based upon that of Rossi and Rosenzweig (1955a and b). The counter has 
a spherical shell of inner diameter 12. 7 mm with wall thickness of either 1.3 mm or 
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2.5 mm. Various wall materials are available but for this work the choice was 
restricted to A-150 tissue equivalent (TE) plastic (Smathers et al., 1977) and carbon 
(graphite). These are referred to as tissue equivalent (TEPC) and carbon (CPC) 
proportional counters respectively. The principle of operation is the same irrespective 
of wall material and the electrical characteristics of the two counters were found to be 
very similar. 
When operating these counters conventionally the electrically conducting wall 
(cathode) was kept at ground potential whilst a positive voltage was applied to the 
centre wire (anode) stretching across the diameter of the spherical cavity. The 
spherical shape of the sensitive volume leads to a distortion of the electric field 
towards the ends of the anode ( end effects). To overcome this asymmetry an 
ancillary electrode in the form of a helix is positioned concentrically around the 
anode. By applying an intermediate voltage to the helix with respect to the anode a 
cylindrically uniform field is produced along the entire length of the anode. A divider 
network of resistors installed in the connector box of the detector maintains the bias 
to the helix at 20% of that applied to the anode. The counter is encapsulated in a 
vacuum tight aluminium shell (0.0178 cm thick) at the end of an aluminium stem on 
which electrical connectors and a vacuum fitting for gas filling are mounted. This 
design enabled operation of the counter whilst immersed in a water phantom without 
the need for a continuous gas flow system. 
Counting gas 
The detectors were filled with a propane-based TE gas mixture the composition of 
which is given in Table 2.2. A propane rather than methane-based TE mixture was 
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chosen because of better gas gain characteristics (Srdoc, 1970). The larger signal to 
noise ratio obtained with the propane mixture is particularly advantageous in 
accelerator environments where electronic interference from the generated RF and 
Table 2.2 Elemental composition of propane-based tissue equivalent gas {Srdoc, 
1970). 
Gas Mixture (partial pressures) 
Composition (% weight) 
Density ( at 20' C, 100 kPa) 
Average atomic weight 
Average atomic number 
55.0 % C3Hs, 39.6% CO2, 5.4% N2 
10.3% H, 56.9% C, 3.5% N, 29.2% 0 
1. 798 kg. m -3 
A = 5.871 
z 3.235 
the many power supplies located along the beam line can distort the radiation related 
spectrum measured by the counters. A 2 µm diameter sphere of unit density tissue 
was simulated by filling the counters to a pressure of 8. 7 kPa. After filling, gas gain 
instabilities were observed for a number of hours and as a consequence the counters 
were always charged at least 24 hours prior to use. 
The pressure of the filling determined the maximum applied bias and the onset of 
electrical discharge or arcing inside the counter was monitored by viewing the output 
signals on an oscilloscope. A positive potential of 600V provided sufficient gas 
amplification to register small event sizes that would otherwise be lost in the general 
electronic noise of the system and measured lineal energy spectra extended down to 
approximately 0.2 keV µm-1. 
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Electronics 
The range of event sizes resulting from exposure to a fast neutron field varies over 
five orders of magnitude and it is necessary to record the magnitude and frequency of 
all such events. To ensure suitable pulse height resolution, the counter output pulses 
were amplified utilizing standard nuclear instrumentation modules (NIM electronics). 
A schematic diagram of the experimental set up is shown in Figure 2.5. The output 
signal from the proportional counter is fed into a charge sensitive pre-amplifier where 
an integrated output voltage proportional to the accumulated charge is produced. 
The nominal voltage gain was set such that a charge of 0. 7 pC would produce a 1 volt 
pulse. Thereafter the pulse is shaped and amplified further by a linear spectroscopy 
amplifier which produces unipolar and bipolar signals with preselected timing 
characteristics. Amplitudes ranged from O to 10 V and a time constant of 2 µs was 
chosen to minimise pulse pile-up. This also provided adequate sampling time for the 
analogue to digital converter (ADC) which required a minimum pulse width of 0.5 µs. 
The pole/zero trim on the amplifier was set to minimize over- or under-shooting for 
the unipolar output pulse. 
To accommodate the large range of pulse heights, three linear amplifiers with relative 
gain settings of XlO, XlOO and XlOOO were employed. These settings were adjusted 
using a reference pulser as source for the test input to the pre-amplifier. The 
simultaneous acquisition of all three pulse height spectra ensured that each segment 
was recorded under identical beam conditions and minimized the beam time required 
for a measurement. Each amplifier output (unipolar) was fed to a Wilkinson type 
ADC (100 MHz clock rate) operating in the pulse height analysis (PHA) mode. The 
ADC gain was set to provide a resolution of 1024 channels of equal width for the O -
Figure 2.5 
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Block diagram of the electronic system used for pulse processing and 
data acquisition. Index: ADC = analogue to digital converter1 AMP = 
linear spectroscopy amplifier; HV = high voltage supply, MCA = 
multichannel analyser; PA = preamplifier; PULSER = reference 
pulse generator; TEPC = tissue equivalent proportional counter. 
10 V range of input pulses. The zero intercept of the ADC was set using a precision 
pulser. During irradiation the count rates of the amplifier outputs were monitored by 
a scaler and the beam intensity adjusted so that rates did not exceed 3000 cps in the 
high gain amplifier. Each ADC recorded its own live and true times in channels zero 
and one respectively. The difference between the two was due to the processing or 
dead time of the ADC for a particular count rate. Dead times were negligible for 
both the low and medium gains but would typically be 2% and at worst 5% for the 
high gain stage. The ADCs were equipped with an adjustable lower level 
discriminator which was set at approximately 0.1 V for each stage. The ADCs were 
fed through a router module to a multichannel analyser (MCA) where individual 
pulse height spectra were displayed. Control of the data acquisition process was 
through the MCA which could start or stop the three ADCs simultaneously. Upon 
completion of a measurement the pulse height data for each amplification stage were 
transferred from the MCA to a microcomputer via the standard RS232 interface and 
serial ports where the data were stored on disc for subsequent analysis. 
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Pulse height calibration 
All counters were equipped with internally mounted 244Cm sources to provide pulse 
height calibration in terms of a specific energy loss. Whilst use of the a-source gave 
a good constancy check on the performance (gas gain) of the counter during a series 
of measurements, calibration of the data was performed utilizing the less error prone 
proton edge method (Waker, 1985; Pihet et al., 1992a). When simulating a 2 µm 
diameter sphere of unit density tissue, a value of 180 keV was calculated for the 
maximum energy loss suffered by a proton crossing the diameter of the cavity. Here 
the stopping power data of Andersen and Ziegler (1977) were used. An uncertainty of 
between 5 and 10% is associated with this energy loss but more recent findings 
estimate uncertainties of only about 2% (Waibel and Willems, 1987). A position on 
the lineal energy scale of 135 keV µm-t for the bottom of the proton edge was 
obtained by dividing the maximum energy loss by the mean chord length for the 
simulated spherical cavity (f. = 4/3 µm). The finite width of each lineal energy bin 
was also observed to contribute to the overall uncertainty when positioning the 
proton edge. This source of error was quantified by moving the edge of a spectrum 
by one lineal energy bin which induced a change of 5.6% in the evaluated absorbed 
dose. 
Data reduction 
Data reduction was performed on an IBM compatible microcomputer following the 
conclusion of a measurement which included performing a background run by 
collecting data in the high gain amplifier with the beam off. The background run was 
scaled to the beam measurement by the ratio of the respective live times and data 
subtracted prior to matching the subspectra. Composite frequency and dose 
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distributions of the three measured subspectra were then normalised to unit area. To 
enhance the clarity of data display a logarithmic event size scale was needed. In 
converting the experimental spectrum from a linear to logarithmic scale it was 
important to preserve proportionality between the area under the curve delineated by 
two values of event size and the fraction of the number of events (or dose delivered) 
in that event size interval. This was maintained by constructing plots of yf(y) and 
yd(y) [ = y 2f(y)], both as a function of y after normalization as follows 
Y2 J f(y) dy Y1 
Y2 J y f(y )d ln y = 1 Y1 
and similarly 
Y2 Y2 
J d(y)dy =J yd(y)dlny=l Y1 YI 
To produce these plots the raw pulse height data from each of the subspectra were 
rebinned into a logarithmic lineal energy scale of 40 equal intervals per decade. The 
amplifier gains were set to ensure regions of overlap between adjacent subspectra. 
Each higher gain subspectra was joined to its lower gain neighbour with a 
normalisation factor determined from the ratio of the data in the corresponding 
overlap region. Moving bin by bin through the overlap region an average ratio was 
calculated for ten consecutive bins at a time. The average which agreed best with the 
ratio of the live times for the two subspectra being joined, determined the matching 
region and the normalization factor. The normalization factor seldom differed by 
more than 2% from the ratio of the live times. Low gain data below and high gain 
data above the matching interval were discarded. 
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Figure 2.6 Measured dose 
distribution represented as 
yd(y) versus log y. The 
data was obtained in the 
p(66}/Be(40) neutron beam 
at the NA C therapy facility 
Figure 2.6 shows a typical plot of a dose distribution measured in the N AC therapy 
beam. The event size scale was calibrated by positioning the bottom of the proton 
edge at 135 keV µm-1. This value is an invariant with neutron energy and changes 
only with the volume simulated by the counter. 
Employing the expressions for the averaged parameters defined in ICRU, (1983) the 
frequency mean yF, the dose mean yD and the dose mean corrected for saturation y* 
values were calculated for the binned data as follows 
2 4 0 2 4 0 
YF ~ Y· f(y.) / ~ f(y.) (keV µm-1) 1 1 1 
i = I i = 1 
2 4 0 2 4 0 
~ 2 f(y.) / ~ Y· f(y.) (keV µm -1) YD Y· 1 1 1 1 
i = I i = I 
2 4 0 
-(y. ; y ) 2 2 4 o 
and y* ~ y2 [1 - e 1 o ] f(y.)/ I: Y· f(y.) (keV µm -1) 0 1 1 1 
i = 1 i = 1 
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where i is the bin identification for a particular lineal energy and y 0 
keV µm-1 (Kellerer and Rossi,1972). 
Evaluation of absorbed dose 
123.75 
The determination of absorbed dose by means of a low pressure proportional counter 
is based upon Bragg-Gray cavity theory and requires that 
1. the presence of the gas cavity does not perturb the charged particle fluence 
and that the charged particles lose only a small fraction of their energy in 
traversing the cavity 
and for a wall material and gas filling of different compositions 
2. the absorbed dose in the cavity is deposited entirely by charged particles 
traversing the cavity, i.e. crossers (ICRU, 1983). 
Under these conditions the absorbed dose in the wall Dm is related to the absorbed 
dose in the gas Dg by 
WN 
Dm = - . r . Dg W m,g 
C 
where r is the gas-to-wall dose conversion factor and WN/W the average energy 
m,g C 
required to create an ion pair in the gas by neutron induced secondaries relative to 
that for the calibrating radiation. If secondary charged particle equilibrium is 
established in the wall then Dm is also equivalent to the total kerma. The absorbed 
dose to the gas Dg is evaluated by summation of the measured frequency distribution 
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2 4 0 
C l ~ y. f(y.) 
m I I (Gy) 
i = 1 
where mis the mass of gas in the counter cavity, C the energy conversion factor (keV 
to Joules) and l (µm) the mean chord length. 
The parameter r is the ratio of the average mass collision stopping powers for the m,g 
wall and gas. In the case of a homogeneous detector with walls and gas of the same 
atomic composition, density corrections to the stopping powers are neglected and a 
value of r = 1.00 ±0.02 is assumed (ICRU, 1989). When the walls and gas cliffer in m,g 
composition however, r has to be evaluated. In a high energy neutron beam m,g 
(En>20 MeV) this is problematic as the secondary charged particle spectra produced 
in the wall material are not well known. The TEPC with TE gas filling used in these 
stuclies was considered a homogeneous detector (i.e. r = 1) and the CP C /TE gas 
m,g 
mixture an inhomogeneous system for which r values were empirically determined. 
m,g 
The W-value or energy required to produce an ion pair m the gas filling vanes 
between the different species of charged particles produced by the neutron 
interactions in the wall material, tending to increase with decreasing particle energy 
(velocity) as more energy is expended in non-ionizing processes. This has been 
demonstrated in propane-based TE gas for different ions in the energy range 25-375 
keV (Posny et al., 1987). Recent estimates for propane based TE gas show no 
significant clifferences in the W-values for 100 keV protons (i.e. those used in the 
proton edge calibration method) and 700 keV alpha particles (Pihet et al., 1992a) and 
a value of unity was adopted for W N/W c· A different W-value was considered 
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necessary in the evaluation of the photon dose fraction where the secondary charged 
particle spectrum only contains electrons. A ratio for W e/W N of 0.94 was adopted 
(Goodman and Coyne, 1980 ). 
Uncertainties of measurements 
When using low pressure proportional counters, uncertainties in the measured 
absorbed dose to the counter wall are attributed largely to the conversion of 
ionization yield to an energy deposition spectrum and in calibration of the pulse 
height data. Converting the ionization yield measurements to energy deposition 
spectra also necessitates approximations as unique W-values cannot be associated 
with each pulse height because different secondaries with different W-values can give 
rise to events of identical pulse heights. Counting statistics are another source of 
uncertainty but were minimised by ensuring that the counters received a dose of 
between 1 and 5 cGy during an irradiation. The principal sources of uncertainty are 
itemized in Table 2.3 and together totalled 8.2% when added in quadrature and 
expressed as one standard deviation. This estimate is believed realistic and compares 
with the 7.2% uncertainty quoted for a CPC measurement in a 42 MeV neutron field 
after a thorough error analysis. (Schrewe et al., 1992a). 
In quoting values for the average microdosimetric parameters overall uncertainties of 
10% and 6% have been associated with yF and Yu respectively (Waker, 1985). 
However, systematic errors such as calibration uncertainties are less important m 
studies of comparative changes as utilized in this work and instead the statistical 
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Table 2.3 Principal sources of uncertainty in the determination of absorbed 
dose to the counter wall. 
Source Reference Error 
% 
Proton edge position (This work) 5.6 
Stopping power data for ( Andersen and Ziegler, 1977) 5 
protons 
Constant W-value approxi- (Pihet et al., 1922a) 3 
mation 
Counting statistics (Menzel et al., 1984) <1 
uncertainty for a single measurement is more pertinent. Experience of repeated 
measurements over an extended period realised standard deviations better than 6%, 
2% and 1 % respectively for yF' Yn and y* (Binns and Hough, 1988). 
Spectral characteristics 
Dose distributions in lineal energy measured in neutron fields exhibit features that 
can be ascribed to identifiable physical processes. Figure 2. 7 shows a dose 
distribution measured in a d(14) + Be neutron therapy beam with a Rossi-type 
proportional counter simulating a unit density sphere of tissue 2 µm in diameter 
(Fidorra et al., 1980). Separate contributions to the total absorbed dose from 
different components making up the secondary charged particle spectrum can be 
recognised. Prominent is the proton recoil peak centered near 10 keV µm -1 and the 
slow recoil protons at approximately 70 keV µm-1. The right hand edge of the proton 
peak corresponds to the maximum energy loss that a proton can undergo inside the 
counter. Energy depositions by a-particles and heavy recoil nuclei are evident above 
the proton edge whilst events extending down to 0.1 keV µm-1 are attributed to recoil 
electrons following Compton scattering of photons. 
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Dose distribution measured in a d(14)+Be neutron therapy beam 
separated into the four radiation components: gamma rays (fast 
electrons), fast recoil protons, slow recoil protons, alpha and heavier 
recoil ions (reproduced from Fidorra et al., 1980). 
Photon dose evaluation 
The presence of photons in a neutron therapy beam is unavoidable as they are 
produced at the neutron source and in the collimator as well as within the patient. 
The amount of contamination is expressed as the photon dose fraction (PDF) and is 
given by the quotient of the photon dose by the total dose measured at a particular 
point. The PDF is usually provided as additional information in therapy protocols. 
Assessment of the PDF with a TEPC is relatively straightforward and is considered 
more reliable than with the twin ionization chamber method (Weaver et al., 1977) 
where the neutron sensitivity of the supposedly neutron insensitive detector continues 
to be a limitation for accurate evaluations. 
The TEPC technique utilizes the fact that the electrons set m motion by photons 
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have lower LETs and hence smaller y values than the proton and heavy recoils 
produced by neutron interactions. Although the exact nature of the photon energy 
spectrum for the p(66)/Be( 40) therapy beam is unknown, measurements in a 
hydrogenous phantom can be expected to comprise largely of photons with energies 
2.2 MeV resulting from neutron capture reactions (Menzel and Waker, 1976). 
Consequently the dose distribution for a pure 24Na source (E =2.75 MeV) was 
'Y 
considered representative of the photon component and a single event spectra for this 
source was measured for all event sizes greater than 0.1 keV µm-1. This lower 
threshold was achieved by performing the measurement in a laboratory distant to the 
therapy vault where the electronic noise level was much reduced. Below the 
measurement threshold the frequency distribution was extended to lower event sizes 
by applying a zero slope extrapolation to the data (Stinchomb et al., 1980). All dose 
distributions obtained in neutron fields were extended to lineal energies below 
0.25 keVµm-1 by fitting the 24Na spectrum to the measured single event spectra. 
Using normalised dose distributions the pure photon spectrum was scaled to that of 
the neutron measurement in the region of 0.25 - 0.4 ke V µm -1. This interval was 
chosen to minimise errors due to the intrusion of the fast proton tail observed in high 
energy neutron beams. The scaling factor gives the ratio of the photon to total dose 
that is measured with the TEPC assuming W N = We· The factor was then 
multiplied by the ratio of W efW N (i.e. 0.94) to yield the PDF measured in the mixed 
n/ 'Y radiation field. 
CHAPTER 3 
NATIONAL ACCELERATOR CENTRE 
Introduction 
The National Accelerator Centre (N AC) at Faure, South Africa, is a multi-
disciplinary research institute established m 1977. Experimental facilities and 
particle beams are provided for radiotherapy, the routine production of medical 
radioisotopes, and nuclear physics research. A layout of the main facility is shown in 
Figure 3.1. Two small solid-pole cyclotrons serve as injectors or pre-accelerators for 
the much larger separated-sector cyclotron (SSC) (Botha et al., 1991). The first 
injector (SPCl) is equipped with an internal ion source to produce the intense beams 
of light ions necessary for particle radiotherapy and radioisotope production (Du Toit 
et al., 1987). The second injector (SPC2) is still under construction and will provide 
heavy ion and polarised light ion beams. SPCl can accelerate protons up to an 
energy of 8 MeV for injection into the first orbit of the SSC. The SSC is a variable 
energy machine designed to accelerate protons to a maximum energy of 200 MeV. 
Once the acceleration process is complete, particles having reached the required 
energy are ready for extraction, and are then transported along the various beam 
lines to a designated irradiation area. 
Beam time for neutron therapy is available for three working days a week, Tuesdays, 
Wednesdays and Thursdays. Patients are accrued countrywide by referral to the 
radiotherapy departments of either Groote Schuur or Tygerberg which are the main 
teaching hospitals for the area. NAC is conveniently situated between these two 
hospitals, and patients are either admitted daily as out-patients or accommodated in 
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the 30 bed hospital on-site. The most recent figures available show that 419 patients 
have been treated up to the end of 1992. 
A brief description of the therapy and other irradiation facilities used in this work 
follows. 
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Figure 3.1 Layout of the NAG cyclotron facility. 
Neutron therapy facility 
At the radiotherapy facility the neutron producing target is housed inside an 
isocentric gantry located at the end of the beamline in vault TC (Figure 3.1 ). 
Figure 3.2 shows a schematic of the gantry which is capable of ± 185° rotation and 
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includes a collimator with a continuously variable aperture providing field sizes from 
5.5 x 5.5 cm2 to 30 x 30 cm2 at a source-to-axis distance of 150 cm. The beamline 
components in the gantry include a number of magnets which bend, focus and steer 
the proton beam onto the target. A separate insulated annulus upstream of the beam 
scanner and the scanner itself provide diagnostic information for centering the beam 
inside the beamline. Heat dissipation in the target limits maximum proton beam 
intensities to 30 µA. 
Neutrons are produced by impinging 66 MeV protons onto a 19.6 mm thick beryllium 
target (Jones et al., 1988). Only 40 MeV of the incident beam energy is dissipated in 
the target which is encapsulated in a 0.55 mm thick cylindrical copper jacket. A 
2 mm air gap at the far side of the jacket allows for possible heat expansion of the 
beryllium. The protons are finally brought to rest in a 1 mm copper plate which is 
cooled on both front and back surfaces by 1 mm of flowing water. The end of the 
copper target assembly is 3 mm thick. The beam is pre-collimated by 13 cm of steel 
before passing through a drawer containing both the hardening and flattening filters 
and an X-ray tube. Thereafter the beam passes through twin transmission ionization 
chambers, a wedge filter carousel and is finally shaped by the collimator. Although 
not initially included, the incorporation of a hardening filter was deemed necessary 
during preclinical calibrations following radio biological and microdosimetric 
investigations (Slabbert et al., 1989). The hardening filter is permanently mounted in 
the beam and consists of a polyethylene sheet 2.5 cm thick. This thickness was 
chosen as a compromise between reducing observed variations in beam potency 
without substantially decreasing the dose rate as target design specifications limit the 
maximum proton beam intensities to 30 µA. The flattening filter assembly contains 
two iron filters. One is permanently in the beam and used for fields with linear 
dimensions less than 16 cm, while both are used for fields with linear dimensions 
greater than 16 cm. 
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Cross-section of the isocentric gantry used for beam delivery in the 
neutron therapy vault at the NA C. 
The "book-€nd" collimator consists of five layers of four interlocking blocks, geared 
to provide a tapered aperture. The three blocks closest to the target are made of pure 
iron while the distant two layers are made of borated polyethylene. The outerblock is 
covered by a 2 cm thick layer of lead on the outside to absorb gamma rays resulting 
from neutron activation of the inner blocks. When there is no beam on target, a lead 
glass shutter 5 cm thick automatically covers the collimator opening. The collimator 
is rotatable through 360° and provides rectangular fields symmetric about the central 
axis. 
Neutron time-of-flight facility 
Measurements utilizing neutron TOF over flight paths of up to 12 m are possible in 
the experimental area marked Din Figure 3.1 (Cornell et al., 1991). A more detailed 
schematic diagram is given in Figure 3.3. Quasi mono-€nergetic neutron beams are 
generated by bombarding a relatively thin target with protons of a particular energy 
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up to a maximum of 200 MeV. The chosen nominal proton energies for this work 
were 30, 45 and 66 MeV. In each instance a 1.1 mm thick beryllium disc served as 
the neutron producing target. The target is fitted into a holder forming part of a 
ladder assembly which provides for a number of such discs and can be pneumatically 
driven. Heat dissipation in the beryllium limited the maximum permissible beam 
intensities to 5 µA. Focusing of the proton beam at the target position was ensured 
by observing the spot size illuminated on a beryllium oxide plate which was 
substituted for the neutron producing target. The plate is mounted at 45° to the 
beam direction and viewed through a system of mirrors and a TV camera. During 
this diagnostic procedure the beam intensity was reduced to below 100 nA by closing 
slits on the transfer beamline between SPCl and the SSC. 
I 
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Figure 3.3 Plan of the neutron 
TOF facility showing the 
detector set up on the 0° 
neutron beam. Collimators at 
other angles are blocked with 
square stainless steel rods. 
High energy protons lose only a fraction of their kinetic energy in traversing the 
1.1 mm thick Be target. To prevent the emergent protons from reaching the point of 
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neutron detection, a dipole magnet is positioned immediately after the target 
assembly. The magnet sweeps away the protons into a Faraday cup at 15° off the 
beam axis. The Faraday cup acts as a beam dump and is well shielded by layers of 
concrete and iron to minimise any stray neutrons which may be produced. Integral 
beam current readings from the Faraday cup served as the principal beam monitor. 
The target and beam dump are situated behind a thick wall of steel and concrete 
which divides the experimental area. The wall screens the irradiation area from the 
target. Collimation of the neutron beam is provided by a 50 x 50 mm square steel 
collimator 1. 7 m long with the exit face 4 m from the target. The collimator has 
several ports at angles to the incident proton beam direction ranging from 0° to 16° 
in increments of four degrees. Irradiations were performed in line with the 0° port 
whilst the other apertures were blocked off by insertion of stainless steel rods. 
The time reference signal required for TOF work was derived from the RF cycle of 
the injector cyclotron. This operates at a frequency of 16.373 MHz for proton 
acceleration by the SSC up to 66 MeV. To further increase the time interval between 
successive proton beam bursts a pulse selector is installed on the transfer beamline 
linking the injector and main cyclotron (Kritzinger et al., 1991). Electrostatic 
deflection of unwanted pulses was possible so that only every fifth pulse was injected 
into the SSC. The resulting frequency was then reduced to 3.275 MHz thereby 
increasing the time separation between beam bursts to 305 ns. The pulse width was 
less than 2 ns. 
Van de Graaff accelerator 
The Van de Graaff facility is situated on the same site as the main cyclotron complex 
but housed in a separate building. The accelerator operates at a terminal voltage of 
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6 MV and routinely delivers beams of light (H+, H2, D+ and He+) and heavy (O+ and 
Ar+) ions for use in nuclear physics research, ion implantation and PIXE analysis. 
Uncollimated monoenergetic neutrons of 2.3 MeV were generated via the T(p,n) 3He 
reaction. Protons of incident energy 3.1 Me V bombarded a stainless steel cell 
containing tritium gas which was maintained at a pressure of approximately 80 kPa. 
The tritium (50 Ci) is stored for convenience and reuse as uranium tritide in a 
separate furnace connected to the gas cell. The system is evacuated and sealed before 
tritium is released into the gas cell by heating the furnace to approximately 400° C. 
Once filled to the required pressure the gas cell is isolated from the storage system 
and the uranium powder (N 5g) allowed to cool. At the end of use the tritium is 
returned to the furnace and reabsorbed by the uranium. When not in use care is 
taken to keep the storage system under vacuum to prevent oxidation of the powder. 
The proton beam was pre---<:ollimated by a tantalum annulus positioned 1 m upstream 
from the cell. This produced a beam spot of 5 mm diameter on the entrance window 
(Havar foil 2.5 µm thick) to the cylindrical cell (diameter 12 mm, length 30 mm) 
where the protons experience an energy loss of 0.13 MeV. Subsequent energy loss and 
heat dissipation in the air cooled cell restricted beam intensities to 1 µA. After 
traversing the length of the target the protons are eventually stopped in a platinum 
backing. The integrated current from the target served as beam monitor for the 
irradiations. 

CHAPTER4 
CHARACTERISATION OF THE FAURE THERAPY BEAM 
Introduction 
It has been suggested by Mijnheer et al. (1987a) that after clinical and radiobiological 
considerations have been taken into account the error in the absorbed dose delivered 
to the target volume should be no greater than ±3.5%, expressed as one relative 
standard deviation. This figure is applicable to both photons and neutrons and the 
uncertainty in the determination of absorbed dose should include the specification of 
radiation quality within the beam. The term radiation quality usually refers to 
differences in the effectiveness of radiation of different modalities or energies and 
varies little if at all for conventional or low LET sources such as 60Co photons and 
high energy X-rays. In contrast for a fast neutron beam the specification of radiation 
quality is complicated by the presence of different types of recoil particles where each 
species spans a separate range of energies and LETs. 
Initially only the relative biological effectiveness (RBE) between neutrons and 
photons was considered to be of relevance in clinical practice. Historically this was 
thought to be the most important factor because the RBE of fractionated neutrons 
relative to fractionated photons was found to be approximately 3. This was 
investigated by means of radiobiological assessments using various biological 
endpoints relevant to therapy (early and late effects in normal tissue). Due to the 
increasing number of neutron therapy centres and the widely differing energies used, 
the need arose to assess the neutron RBE between different neutron therapy beams 
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with the object of comparing clinical results and therapeutic protocols of different 
centres (Wambersie et al., 1990). To this end several studies have been performed 
involving systematic radiobiological (Hall et al., 1979; Beauduin et al., 1989) and 
rnicrodosimetric (Hartmann et al., 1981; Pihet et al., 1990) intercomparisons. Lastly 
it has become apparent that for a particular neutron beam, variations in radiation 
quality with respect to different irradiation conditions needed consideration. 
The early generation of neutron therapy beams mostly exploited the Be(d,n) reaction 
as a radiation source and successful treatments were essentially limited to superficial 
tumours. The variation of radiation quality in the absorbing medium was examined 
and no marked changes in the quality of the neutron component could be found (Zeitz 
et al., 1975; Hogeweg et al., 1978). Nevertheless, because of the comparatively large 
RBE of neutrons relative to gamma rays, it was deemed necessary to account for the 
accompanying photon component which could vary significantly with depth within 
the primary beam. The advent of the new generation of dedicated accelerators with 
isocentric delivery systems saw high energy protons impinging on a semi-thick Be 
target serve as the principal source of fast neutrons. The neutron energy distribution 
for the (p,n) reaction is characterized by a significant low energy component which is 
radiobiologically more effective. Radiobiological and physical measurements have 
demonstrated that unless modified by means of a hydrogenous filter, or a thinner 
target, these neutrons are preferentially scattered out of the beam as it penetrates the 
absorbing medium. As a result of the "hardening" of the neutron spectrum the 
effectiveness of the beam is reduced at greater depths and a variation in the RBE is 
observed (Hall et al., 1982; Homsey et al., 1988). As more facilities of this type are 
commissioned, the weight of experimental evidence grows concerning the variation of 
beam quality with spatial position inside a water phantom (Hill et al., 1991 ). 
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The nature and magnitude of these variations depend upon certain design features, 
for example projectile type and energy, target thickness, beam filtration, collimation 
and shielding, all of which make each therapy facility unique. To systematically 
identify irradiation conditions that bring about variations in beam quality in a 
homogeneous tissue-like medium, required that a comprehensive survey of the 
p(66)/Be(40) therapy beam at the NAC be undertaken. If quality variations can be 
reliably quantified and prove to be of clinical significance, then a discrepancy between 
the prescribed dose at the point of measurement and the effective dose delivered at 
that point must be recognised. 
Materials and Methods 
Radiobiological assays do not readily lend themselves to systematic surveys of 
radiation fields because they are usually time consuming and yield quantities that 
have inherently large uncertainties. An alternative approach is to identify a physical 
parameter that is easily determined and correlates with measured variations in RBE. 
Whilst no biophysical model exists which adequately describes radio biological 
findings relevant to therapy, the measurement of microdosimetric spectra can provide 
comprehensive and detailed information on radiation quality (Menzel et al., 1990). 
The parameter y*, the dose mean lineal energy corrected for saturation, obtained by 
applying a biological weighting function to the measured dose distribution in lineal 
energy has been shown to correlate well with observed changes in RBE for some 
biological endpoints (Stinchcomb et al., 1986; Pihet et al., 1988). Although a more 
clinically relevant function has been devised for comparing different therapy beams 
(Menzel et al., 1990) earlier studies in the N AC therapy beam where beam filtration 
was examined have shown the practical value of utilizing y* measurements to 
45 
demonstrate radiobiologically significant changes in beam quality (Slabbert et al., 
1989). Moreover, previous studies have shown the sensitivity of single event spectra 
to subtle changes in physical beam characteristics for p(66) type beams (Binns and 
Hough, 1988; Pihet, 1989; Taylor et al., 1990). A thorough microdosimetric study 
was therefore considered judicious to fully assess the character of the Faure therapy 
beam and obtain reliable data that could be incorporated into treatment planning 
schedules. 
Microdosimetry measurements were performed with the TEPC and experimental 
system described in Chapter 2. Irradiations were carried out both in-air and 
in-phantom with the detector orientated vertically and perpendicular to the incident 
beam. Horizontal beams were used throughout and all observations made under 
therapy conditions with both the hardening and the appropriate flattening filters in 
position. In-phantom studies were routinely conducted in a 60 x 60 x 60 cm 3 water 
filled tank positioned at an SSD (source surface distance) of 150 cm. The walls of the 
phantom were made of Perspex 1 cm thick. Beam quality as a function of spatial 
position inside the phantom was examined as was the effect of changing field size. In 
addition other conditions relevant to radiation therapy were assessed for quality 
variations. These included the effect of flattening filters and wedges on the beam 
profile and changes in the volume of the irradiated phantom. A separate in-air study 
was made in the dose build-up region using custom made caps of different 
thicknesses. 
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Results 
Depth dose 
Measurements were performed at different depths on central axis to assess the 
effectiveness of the 2.5 cm thick polyethylene hardening filter. Data were obtained in 
a 10 x 10 cm2 field for depths ranging from 2.5 cm to 25 cm, as measured from the 
front face of the phantom to the centre of the detector volume. Normalised dose 
distributions for three different depths are illustrated in Figure 4.1. Qualitatively a 
slight but distinct trend is apparent in the spectra. The dose component associated 
with slow protons in the beam (14<y<140 keV µm-t) is reduced with depth as the 
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In-phantom microdose spectra measured for a 10 x 10 cm2 field on 
central axis at different depths of 2. 5 (- - - ) , 1 0 (-) and 25 cm (- · ·) 
with the permanent 2. 5 cm thick polyethylene filter installed. 
fast proton peak ( 1 <y< 14 ke V µm -t) migrates to slightly lower lineal energies. These 
observations are consistent with a progressive hardening of the neutron beam with 
depth. Similar trends have been noted in other unfiltered p(62)/Be and partially 
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filtered (2 cm polythene) p(65)/Be therapy beams (Taylor et al., 1990; Pihet, 1989). 
Values for the parameters yF and Yo are presented together with the photon dose 
fractions in Table 4.1. Slight decreases in the y F and y D values are indicated as the 
beam hardens and the gamma component increases with depth. 
More relevant to possible variations in beam quality however are changes in y*. 
These are shown in Figure 4.2 for the total beam (neutrons + gammas) and neutrons 
only. A decrease of 6% is noted between depths of 2.5 and 20 cm for both curves, 
indicating that the photon component has an insignificant influence on the variation 
in y*. Microdosimetric studies in other therapy beams generated with high energy 
protons have shown more marked changes. In a filtered p( 42)/Be beam a reduction 
Table 4.1 Depth dose for different field sizes. 
Depth (cm) 
2.5 5.0 10.0 15.0 20.0 25.0 
yF (keVµm-1) 
Field size (cm2) 
5.5 X 5.5 - 4.16 - 3.83 - 3.51 
10 X 10 3.59 3.85 3.59 3.49 3.31 3.28 
20 X 20 - 3.27 3.06 3.02 - 2.82 
Yn (keVµm-1) 
5.5 X 5.5 - 84.8 - 83.6 - 80.8 
10 X 10 83.5 82.1 83.5 83.2 79.4 80.3 
20 X 20 - 82.3 80.3 81.9 - 78.1 
, (% of total dose) 
5.5 X 5.5 - 3.6 - 4.1 - 4.6 
10 X 10 4.3 4.4 5.0 5.2 5.5 5.5 
20 X 20 - 6.1 6.9 7.4 - 7.5 
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in y* of 15% was observed between depths of 2 and 30 cm (Kliauga et al., 1989) 
whilst in the p(65)/Be beam at Louvain-la-Neuve estimated quality variations of 5 -
10% were seen when moving from about 2 cm to 15 cm depth (Pihet et al., 1988). 
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y* -values measured for a 10 " 10 cm2 field on central axis at different 
depths in a 60" 60" 60 cm water phantom. 
In radiation therapy the magnitude of the measured dose in the absorbing medium is 
a function of the dimensions of the radiation field. This effect is attributed primarily 
to scattering in the collimator and to a lesser extent in the medium. This is true for 
both photon and neutron fields and the appropriate output factors required for 
clinical application are needed for both modalities. An important difference, 
however, between photons and neutrons is that for the latter the radiation quality is 
affected by the scattering process. To evaluate these changes in beam quality, 
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single-€vent spectra were measured for different field sizes and at different depths. 
The effect of changing from a 5.5 x 5.5 cm2 to a 20 x 20 cm2 field size at a depth of 15 
cm on central axis is depicted in Figure 4.3. As the field size is increased the slow 
and fast proton components are respectively enhanced and reduced. This is due to 
scattering of the primary neutrons within the collimator as the aperture enlarges with 
field size. Similar findings have been reported (Taylor et al., 1990) where the effect is 
attributed to in-scattering of lower energy neutrons from the expanding beam 
periphery . 
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Figure 4.3 Single event spectra measured on central axis and at a depth of 15 cm 
for a 5.5 x 5.5 cm2 (- · ·) and 20 x 20 cm2 (-) field. 
Measured y*-values as a function of field size and depth (5, 15 and 25 cm) are shown 
in figure 4.4 for square fields 30 to 400 cm 2. The average changes, denoted by i5.y*, 
were 1.4 and 0.7 keVµm-t respectively for neutrons only and the total beam (neutron 
plus photons). The smaller increases noted for the total beam are attributed to the 
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varying '}'-{:Omponent which is shown in Figure 4.5 to increase with both field size 
and depth. From figure 4.4 it is also apparent that the variation of y* between depths 
of 5 and 25 cm is the same for all field sizes investigated, i.e. 6 to 7%. 
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Figure 4.4 y* -values 
measured on central axis 
at different depths as a 
function of field size. 
The averaged variation 
for each of the data sets 
is appropriately stated. 
At the edge of a neutron field confined to a tissue-like medium the overall quality of 
the beam is affected by two competing processes, a degradation of the primary beam 
due to scattering and a sharp increase in the photon component following interactions 
in the medium, principally from neutron capture in hydrogen, nitrogen and chlorine 
(Bewley, 1989). Measurements were performed in the penumbra to assess the nature 
and magnitude of quality changes in this region. 
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Figure 4.5 The photon 
dose component in the 
therapy beam measured 
on central axis at 
different depths and for 
different field sizes. 
Experimental data were obtained in a 10 " 10 cm2 field at a depth of 10 cm on central 
axis and for a range of lateral displacements. The quality variations were assumed to 
be symmetric about the central axis. Single event spectra measured at displacements 
of 5.5 and 8 cm from central axis are shown in Figure 4.6. These positions correspond 
to absorbed dose levels of respectively 40% and 10% of that on central axis. Marked 
changes are apparent at the edge of the field. The measurement at 5.5 cm off axis 
cannot be distinguished from the measured central axis spectrum whereas that 
obtained 8 cm from central axis shows a relative enhancement in the number of slow 
recoil protons accompanied by a decrease in the fast proton component. This is 
consistent with neutrons undergoing greater scattering in the penumbra and 
consequently suffering larger energy losses. Concomitant with this is a decrease of 
the alpha and heavy recoil components in the dose distribution. As the neutron 
energies are reduced there are fewer neutrons possessing the required threshold energy 
for interactions which lead to alpha and heavy ion production. Further, the photon 
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dose fraction is seen to increase substantially, primarily through neutron capture 
reactions. These trends have been reported for other collimated beams generated 
with either high energy protons (Stafford et al., 1987; Pihet, 1990) or low energy 
deuterons (Fidorra and Booz, 1981; Hough and Binns, 1990) bombarding beryllium 
targets. 
A radiation quality profile together with the corresponding photon contributions for 
the Faure therapy beam are presented in Figure 4. 7. The pronounced increase in y* 
n 
between displacements of 5 and 10 cm suggests a far more effective neutron 
component, exemplifying energy degradation due to scattering. This enhancement in 
effectiveness is tempered by the rapidly increasing photon component and a 7% 
increase in y* is noted before the potency of the beam beyond the penumbra is 
reduced. Qualitatively the data are in good agreement with the transport calculations 
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Figure 4.6 Lineal energy spectra measured for a 10 x 10 cm field at a depth of 10 
cm on central axis ( - - - ) and at displacements of 5. 5 (--) and 8. 0 
cm ( · ·). 
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Figure 4.8 y*-values determined from 
transport calculations for a 15 Me V 
neutron beam and an ideal aperture 
(reproduced from Burger et al. 1 1978) 
performed for 15 MeV neutrons assuming an ideal aperture (Burger et al., 1978). 
These are shown in Figure 4.8 where the magnitude of the calculated variations 
appear much greater for the lower energy beam than for p(66)/Be( 40) neutrons. 
Wedge filter 
Measurements were performed at 2.5 cm depth inside a solid nylon phantom 20 x 20 x 
20 cm3 which was positioned with its front face at an SSD of 150 cm. This phantom 
size was considered appropriate because wedge filters are often used in instances of 
extreme body curvature such as irradiations of the head and neck to correct for the 
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angle of oblique beam incidence. Uniformity of beam quality was examined across a 
45' skewed lateral profile. This is the most slanted isodose distribution used in 
treatments at the N AC. A wedged shaped tungsten block, 4 cm at its thickest, was 
mounted transversely to the beam on a carousel in the treatment head. Uniformity 
in beam quality was examined across the lateral profile of a 16 x 16 cm2 field which is 
the largest field size accommodated by the 45' shaping wedge. The results of 
measurements performed on central axis and at 5 cm on either side are presented in 
Table 4.2. These positions were chosen as they spanned a large portion of the field 
width but were distant from the penumbra. No discernible differences across the face 
of the wedge are apparent. Spectra measured at 5 cm either side of central axis are 
shown in Figure 4.9. The spectra appear indistinguishable from each other except in 
the region of the proton edge where the measurement at the thicker end of the wedge 
Table 4.2 Average parameters for measurements at different lateral positions in a 4 5' wedge field ( 16 x 16 cm2). Negative displacement is towards the thin 
end of the wedge. 
-~ 
Displacement -5 0 +5 
(cm) 
yF (keV µm-t) 3.67 3.63 3.61 
Yn (keV µm-t) 68.6 69.9 67.6 
y* (ke V µm -t) 23.3 23.3 23.3 
' (%) 4.5 4.6 4.6 
appears to have a perceptively larger slow proton component. This may result from a 
slight energy degradation due to neutron scattering in the tungsten but is not 
considered significant. 
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Figure 4.9 
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Microdose spectra measured 5 cm either side of central axis for a 16 x 
16 cm2 field accommodating a 4 5° shaping wedge. The solid curve was 
obtained at +5 cm which was towards the thicker end of the wedge. 
Flattening filter 
Steel flattening filters are positioned in the beam close to the target to produce a 
more uniform or flat isodose distributions at a selected depth. The use of these filters 
give rise to dose enhancements or "horns" at the surface and at depths extending to 
10 cm (Figure 4.10). 
Measurements were performed for a 30 x 30 cm 2 field, the largest in clinical use at the 
NAC. Only in-air data were obtained with additional build--up provided by a 
16 mm thick cap of A-150 plastic. Irradiations were performed with the detector at 
an SAD of 150 cm and 10 cm off axis, the displacement corresponding to the point of 
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maximum surface dose enhancement. Both flattening filters were incorporated in the 
beam, as clinically appropriate for this field size. Employing the transmission 
chamber in the collimator head assembly as dose monitor, nearly identical spectra 
and data were obtained (Figure 4.11 and Table 4.3). The measured dose 
enhancement at 10 cm displacement was 1.09 and is consistent with earlier dosimetry 
data for this field size (Jones and Yudelev, 1988). 
Phantom size 
To assess the influence of phantom size on the noted quality variations with depth, 
measurements were performed for a 10 x 10 cm2 field in a solid nylon phantom 
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Figure 4.11 
Table 4.3 
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Dose normalised lineal energy spectra measured in-air for a 30 x 30 
cm field at an SAD of 150 cm on central axis(-) and 10 cm{---) 
off axis. The displacement corresponded to the point of maximum 
surface dose enhancement. 
Average parameters for flattening filter assessment. In-air measure-
ments performed for 30 x 30 cm2 field on central axis and at position of 
maximum surface dose enhancement {10 cm off axis). 
Displacement 
(cm) 
yF (keV µm-1) 
Yo (keV µm-1) 
y* (keV µm -1) 
'Y (%) 
Relative dose 
0 
4.06 
80.9 
24.4 
4.14 
1.00 
10 
4.11 
80.6 
24.3 
4.02 
1.09 
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10 x 10 x 20 cm3 positioned with the front face at an SSD of 150 cm. This phantom 
size was chosen to minimise scattering within the medium outside the field periphery 
but was extended enough to allow for an adequate range of depth dose measurements. 
A variation of approximately 6% in y* was again observed when moving, in 5 cm 
increments, from 2.5 to 17.5 cm. This is in agreement with the earlier findings in a 
60 x 60 x 60 cm 3 water phantom. Further measurements were performed varying the 
phantom size whilst at a constant depth of 2.5 cm. Positioning the detector in two 
solid nylon phantoms of sizes 10 x 10 x 10 cm 3 and 20 x 20 x 20 cm 3 revealed no 
spectral changes and yielded average parameters that were not statistically different 
(Table 4.4). 
Table 4.4 
Build-up 
Assessment of phantom size for a measurement at 2.5 cm depth in a 
10 x 10 cm2 field. 
Phantom size lOx lOx 10 20x20x20 
(cm3) 
yF (keV µm -1) 3.73 3.53 
Yo (keV µm-1) 67.8 67.5 
y* (ke V µm -1) 22.8 22.8 
'Y (%) 4.4 4.2 
The secondary charged particles produced following neutron interactions in tissue are 
projected predominantly in the forward direction and consequently a transition zone 
exists in the absorbing medium in which secondary charged particle equilibrium is 
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established. In a fast neutron beam the extent of this zone is determined by the 
recoil protons which have the longest range. As the composition of the recoil 
spectrum in the build-up region alters, the quality of the radiation will change 
(Broerse et al., 1968; Bewley et al., 1974). 
In the Faure therapy beam secondary charged particle equilibrium (i.e. full build-up) 
is established at a depth of 17 mm in A-150 plastic (Jones et al., 1988). To simulate 
different positions in the build-up region a series of caps having various wall 
thicknesses were manufactured to fit over the aluminium housing of the TEPC. No 
special electrical properties were required of the material from which the caps were to 
be made and the possibility of using more freely available hydrocarbons as substitutes 
for A-150 was examined. For this study caps of wall thickness 16 mm were 
manufactured from A-150 plastic, nylon (type 6) and polyethylene. This thickness, 
combined with the inherent wall thickness of the detector (1.3 mm) was sufficient to 
provide full build-up. Irradiations were performed in-air for a 10 x 10 cm2 field with 
the centre of the detector positioned at an SAD of 150 cm. Using the transmission 
chamber as fluence monitor, the different detector/build-up cap combinations were 
exposed to the beam and the absorbed doses evaluated. Figure 4.12 shows the three 
fluence normalised spectra. Whereas no significant differences were observed between 
measurements performed with the A-150 plastic and nylon caps, a clear difference 
was manifest when polyethylene was used. The enhanced fast proton component and 
the associated higher dose recorded for the same exposure are quantified together 
with microdosimetric parameters in Table 4.5. The larger proton recoil component 
measured with the polyethylene cap is due to the higher hydrogen content and 
accounts for the enhanced dose. 
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Fluence normalised microdose spectra obtained in the p(66}/Be(40) 
therapy beam. In-air measurements were performed with different 
build-up caps of similar thickness placed over the TEPC 
manufactured from polyethylene (- · · ), A -150 plastic (-) and 
nylon (- - -). 
Satisfied that nylon (type 6) was a suitable build-up substitute for A-150 plastic in 
the p(66)/Be( 40) neutron beam, additional nylon caps were made with 2, 4 and 8 mm 
thick walls and irradiations performed under the same conditions as above. Single 
event spectra obtained with no build-up cap and with caps of wall thickness 2 and 16 
mm are shown in Figure 4.13. The distributions are again normalised to unit neutron 
fluence and not unit absorbed dose. The increasing wall thickness has no apparent 
influence on the spectrum for either the alpha particle or heavy recoil components, as 
seen for lineal energies above the proton edge (y> 140 keV µm-t). The intrinsic 
wall thickness of the counter is 1300 µm and ensures charged particle equilibrium for 
a-particles that are produced in a p(66)/Be(40) beam (ICRU, 1977). 
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Table 4.5 Microdosimetric parameters determined from single- event spectra 
measured using different build-up caps. Dose fractions were calculated 
for two lineal energy regions; y<140 and y ~ 140 keV µm-1 and expressed 
as a ratio. 
A-150 plastic 
Nylon (type 6) 
Polyethylene 
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Figure 4.13 
Hydrogen YF Yn y* Dose Relative 
fractions dose (% weight) (keV µm-t) (y<140)/(y~140) 
10.2 4.22 86.5 24.0 5.15 1.00 
9.8 4.55 86.6 24.3 5.11 0.99 
14.4 4.31 81.7 23.1 5.56 1.08 
,. ' r ~ 
~ l 
J 
' I 
Fluence normalised microdose spectra measured in the p(66)/Be(40) 
therapy beam using a bare TEPC(- · ·) and with nylon build-up caps 
of 2 (-) and 16 mm(---) wall thickness. 
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In contrast, the peak in the dose distribution centered at approximately 10 keVµm-1 
and associated with the fast proton component is significantly enhanced with 
increasing build-up. Similar findings have been reported for measurements 
performed in a 60.3 MeV quasi-monoenergetic beam (Menzel et al., 1988) where the 
build-up region extended over greater thicknesses due to the higher average energy of 
their beam. In Figure 4.14 a curve depicting the dose build-up in A-150 plastic has 
been fitted to data points obtained from extrapolation chamber measurements (Jones 
et al., 1988). Values for the TEPC measurements are also plotted and indicate good 
agreement with the extrapolation chamber measurements. Evaluated data for each 
position on the curve are summarised in Table 4.6. 
The decrease in y* ( and hence beam effectiveness) with increasing build-up correlates 
with the increasing fast proton recoil component. This trend is also reflected in the 
ratio of the dose fractions above and below the proton edge listed in the table. The 
small but increasing photon dose fraction is not considered significant. An increase of 
24% in y* between positions corresponding to full build-up and 71% of dose 
Table 4.6 Microdosimetric parameters evaluated from single - event spectra using 
nylon build-up caps of different thicknesses. The dose distributions 
were fluence normalized to determine the dose relative to that at full 
build-up (last column). 
Thickness Build-up YF YD y* D Dose Relative 
' cap fractions dose (mm) (g cm -2) (keV µm-1) (%) (y~ 140)/(y< 140) (%) 
0 0.143* 5.87 116.9 29.9 2.5 0.309 71.0 
2 0.368 5.16 100.5 26.9 2.7 0.247 85.1 
4 0.593 4.94 93.3 25.8 2.8 0.224 91.1 
8 1.043 4.67 88.2 24.7 3.0 0.205 97.0 
16 1.943 4.47 84.6 24.2 3.2 0.193 100.0 
* Counter wall thickness, no build-up cap 
Figure 4.14 
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maximum is noted. As yet unpublished data with the CHO-K 1 cell line indicates an 
increase in RBE of 73% between a depth of 17 mm and the surface (Slabbert et al., 
1991). Radiobiological results from other p(42) and p(66) therapy beams have shown 
20 to 30% increases in the effectiveness of the beam when moving from the maximum 
build-up position to I mm depth (Hall et al., 1992). 
To complement these studies, the effect of using a 16 mm thick A-150 build-up cap 
inside a water phantom was investigated. Data were obtained in a 10 x 10 cm2 field 
with the detector at a depth of 17.5 cm inside a 30 x 30 x 30 cm3 water phantom. 
Dose distributions measured with and without a cap are shown in Figure 4.15. 
Within the limits of experimental error, no discernible differences are apparent and 
all average parameters agree as do the registered absorbed doses per unit neutron 
fluence as monitored by the transmission ionization chamber (Table 4.7). 
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Figure 4.15 Lineal energy spectra measured on central axis at a depth of 17. 5 cm 
in a water phantom with (-) and without ( - - - ) a 16 mm thick 
A-150 build-up cap placed over the TEPC. 
The findings are at variance with Taylor et al., (1990) where differences compatible 
with a variation in depth in an unfiltered p(62)/Be beam were reported when using a 
cap. Their observed increase in the height of the proton edge when using the cap was 
attributed to (n,p) scattering from carbon in the A-150 plastic. To substantiate this 
supposition would, however, require that the spectra be normalised to unit neutron 
fluence. 
Table 4. 7 Comparison of average parameters for in phantom measurements with 
and without a TE cap. 
Parameter Cap No Cap 
yF (keV µm-t) 3.27 3.29 
Yo (keV µm-t) 71.5 68.6 
y* (keV µm-t) 22.5 22.1 
' (%) 5.6 5.4 
Dose (Gy) 3.07 3.07 
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Discussion 
When irradiation conditions are altered, changes are observed in the shape and 
derived averages for the measured lineal energy spectra. These variations can be 
ascribed to quality changes in the neutron component or to a combination of changes 
in both the character of the neutron component of the beam and quantitative 
variations in the photon dose fraction. These changes can be understood in terms of 
neutron scattering within the phantom and also the collimator when the aperture is 
altered to define different field sizes. Whilst no meaningful deduction can be made 
about Yy and Yn, the parameter y* appears to provide a reliable and sensitive 
indicator of subtle variations in the physical characteristics of the field. 
Depth dose studies between 2.5 cm and 20 cm show that y* decreases by 6%, 
irrespective of field and phantom size. Variations in y* with increasing depth 
n 
demonstrate that the reduction in beam effectiveness is due to changes in the 
character of the high LET recoils. Progressive hardening occurs as low energy 
neutrons are preferentially scattered out of the beam as it penetrates the medium. As 
these neutrons are radiobiologically more effective their removal from the beam leads 
to an overall decrease in beam potency. The slight increase in the photon dose 
fraction does not play a role in the observed changes. 
Changes in field size cause a 3% variation in beam quality, irrespective of depth. 
This is primarily due to an increase in the number of collimator scattered neutrons 
and is mostly evident when altering the field size from 30 cm2 to 200 cm2. This effect 
is tempered for all field sizes by a growing in-phantom photon component. 
Moving across the lateral plane of the field reveals a uniformity in beam quality until 
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the periphery of the collimated field is reached. A maximum increase in y* of 7% is 
noted in the penumbra! region where two competing processes occur. A dramatic 
increase in the effectiveness of the neutron component due to multiple scattering is 
countered by the sharply rising photon component. At shallow depths where the 
lateral dose profile is marked by "horns", the inclusion of a field flattening filter 
produces no untoward effects as regards beam quality. Incorporating a field shaping 
wedge also appears to have no appreciable effect on beam quality. 
Studies in the build-up region demonstrate the value of being able to identify the 
individual components which contribute to the total absorbed dose. Whilst the 
neutron energy spectrum for the Faure therapy beam might be expected to change 
little in the first few millimetres of depth in tissue, changes are easily perceived in 
the measured lineal energy distributions. Smaller doses in the build-up region result 
from a reduced proton dose component and dramatic changes in y* are evident as the 
high LET dose contribution (y > 140 keV µm-1) increases accordingly. Relative to 
the effectiveness observed in A-150 at full build-up, the beam is 24% more potent at 
a depth of 1.3 mm. 
Variations in beam quality have now been quantified for different irradiation 
conditions in a p(66)/Be( 40) therapy beam and suggest that variations in RBE do 
occur within the patient. In terms of dose to the tumour and surrounding tissue, 
these findings are important and should be further considered in clinical applications. 

CHAPTER 5 
TREATMENT PLANNING 
Introduction 
In radiation therapy the required accuracy for the delivery of absorbed dose to the 
target volume is determined by the steepness and separation of the dose response 
curves for local tumour control and normal tissue complications. Examples of 
dose-€ffect curves following neutron and photon patient treatments are shown m 
Figure 5.1 where it can be seen that the steepness of the curves for normal tissue 
complications are similar for the two radiation types (Wambersie and Gueulette, 
1984). This implies that the same level of accuracy is reqwred for each modality and 
that any variation in the delivered dose will modify tumour control and possibly 
affect the complication rate. 
Figure 5.1 
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Dose-effect relationships for tumour control {1) (open symbols) and for skin and intestinal damage {2) {closed symbols) after neutron (o) 
and photon {!J.) irradiation of T4B bladder tumours. The curves for 
skin and intestinal damage are almost identical and onl~ one curve is 
shown {reproduced from Wambersie and Gueulette, 1984)-
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Evidence of a relatively steeper dose-response curve for normal tissue complications 
illustrates the dilemma confronting radiotherapists as in practice it is often this 
restriction that governs the permissible dose to the tumour. There exist widely 
differing clinical situations where some complications are totally unacceptable (e.g. 
spinal cord necrosis) and others where an incidence of varying severity is acceptable if 
high tumour control is demanded (e.g. apical lung fibrosis). A review of clinical data 
for photon treatments suggests that the probability for normal tissue reactions rises 
from 25 to 50% for a relative dose increase of between only 4 and 10% (Mijnheer et 
al., 1987a). It was further concluded that changes of 10% in the target absorbed dose 
could be detected in clinical practice. 
Subtle variations in beam quality will undoubtedly undermine attempts at achieving 
the desired accuracy for the physical dose delivered to the tumour volume. 
Cognizance should therefore be taken of any possible changes and if significant, these 
must be accommodated in the dose prescription. 
Effective dose 
The observed variations in relative quality of the Faure beam with depth, field size 
and lateral displacement have been demonstrated in the preceding chapter. The 
effect with depth resulting from inadequate filtration of the primary beam has been 
observed in two independent radiobiological assays using V79 fibroblasts and crypt 
cell regeneration in mice (Slabbert et al., 1989; Bohm et al., 1990). The latter in vivo 
study assumes particular importance because of its sensitivity and wide acceptance as 
a biological model appropriate for beam calibrations. Compared with its effectiveness 
at a depth of 2.5 cm in water, the potency of the beam is significantly reduced at 
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20 cm depth, so that the same dose delivered at both positions would not result in the 
same effect. To obtain the same biological response at the greater depth, a 6% larger 
dose would be required. 
A decrease in beam effectiveness is correlated with a reduced slow proton component 
(14 ~ y < 140 keVµm-1) and a concomitant increase in dose contributions from the 
fast protons (1 ~ y < 14 keVµm-1) and alpha and heavy ions (y ~ 140 keVµm-1). The 
relative proportions per unit dose of these components (i.e. dose fractions) are given 
in Table 5.1 where qualitative changes in the measured microdose distributions are 
quantified for different irradiation conditions. The variations evident in the dose 
fractions when altering the square field size from 30 cm2 to 400 cm2 are similar to 
those observed with and without a beam hardening filter. The changes in the 
microdose spectra for different field sizes are then analogous to those obtained in the 
depth dose study where varying filtration conditions pertain. Similarly changes to 
the single event spectra measured in the penumbra and beyond (Figure 4.6) also 
exhibit the same trend of y* increasing due to an enhanced slow proton component. 
Confidence is therefore given to the assertion that for the irradiation conditions 
observed the measured changes in y* reflect actual variations in beam quality. 
Table 5.1 Dose fractions determined at 15 cm depth for different field sizes. 
Indicated in brackets are those fractions measured in the beam with no filtration and with a polyethylene filter of thickness 7 cm (Slabbert et al., 
1989). Variations in the dose fractions are also stated. 
--- ------·--. 
Field size 1 ~ y < 14 14 ~ y 140 y ~ 140 Filter ( cm2) (keV µm -1) (keV µm -1) (keV µm -1) thickness 
(cm) 
·--··· 
400 0.501 f 0.463] 0.342 f 0.392] 0.157 f 0.1451 0 30 0.534 0.500 0.304 0.350 0.162 0.150 7 
6D (%) +6.6 [+8.0] -11.1 [-10.7] +3.2 [+3.4] 
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It is not within the scope of this work to discuss the complex problems of relevant 
RBE values for clinical use nor the influence of dose rate and dose fractionation on 
this RBE. The aim is rather to demonstrate that the relative changes noted in beam 
quality pose a hitherto unaccounted for source of error that can be eliminated. 
Previously for the low energy neutron facilities the high-LET component was seen to 
remain constant throughout and differences in overall beam quality were attributed 
solely to variations in the magnitude of the accompanying photon component (Booz 
and Fidorra, 1981; Beach and Milavickas, 1982). Attempts have been made to 
obtain an effective total dose for such beams by weighting the photon dose fraction 
by the inverse of a derived RBE for the neutrons in the beam relative to the photons 
(Kellerer and Rassow, 1980; Field and Joiner, 1990; Rassow et, al., 1990). This 
approach is inadequate for p(66)/Be type beams where actual changes in the neutron 
component itself occur which have a more marked effect on the resultant beam 
quality, and hence the effective dose, than the varying photon dose fraction 
(Wambersie and Mijnheer, 1990). Whilst investigations in a d(14)+Be beam were 
of little consequence due to an absence of any real variations in neutron beam quality 
(Schmidt and Hess, 1988), no such study has yet been performed for a p(66)/Be beam 
where larger differences can be expected. In this study microdosimetric spectra are 
utilized to derive relative effective doses in a neutron therapy beam. 
To examine the influence of these changes in the Faure beam and to estimate any 
discrepancies that may result in the effective dose to the tumour and surrounding 
healthy tissue, it is proposed that the measured y*-values be employed to derive a 
range of weighting factors. These weighting factors can then be applied to modify the 
conventional dosimetry input data to a treatment plan schedule, as measured with 
tissue equivalent ionization chambers, and differences quantified between the physical 
prescribed dose and the resultant effective dose to the tumour volume. 
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In the Faure beam secondary charged particle equilibrium is attained at a depth of 17 
mm and this point was adopted as reference position. The conventionally measured 
total doses Dt were then weighted accordingly and an effective or biologically 
equivalent depth dose curve calculated for depths ranging from 1. 7 to 20 cm as 
follows (Binns and Hough, 1992) 
D = D [(C C d + y* )/y* ] 
eff t I sf ref ref 
(1) 
where d is the depth past the point of maximum build-up and varies from O to 18.3 
and y* (=28.1 keVµm-1) is the y*-value at maximum build-up. Beyond 20 cm 
ref 
depth (i.e. d = 18.3) y* ceases to change. C represents a sensitivity factor assessed 
sf 
by clinicians from clinical and radio biological data. C 1 ( = --0.0805) is obtained from 
a linear fit to the (neutron + photon) data of y* versus depth shown in Figure 4.2 
using commercial software+. In the build-up region a constant y*-value equal to 
y* was applied as this study was only concerned with examining the effective doses 
ref 
to deep seated tumours and the surrounding healthy tissue. 
An increase in effectiveness is noted with increasing square field size irrespective of 
depth and if normalised to a 100 cm2 field size, y* decreases by 2% and increases by 
1 % when going to smaller and larger field sizes respectively. Field size related 
variations in the effective dose can be quantified using the following expression: 
D' = D [ C2(A/100) 100/ A + C3] 
eff t, 100 
(2) 
+ Sigmaplot Computer Graphics System 
Jandel Scientific, Corte Madera, California 94925, USA 
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where Dt, 100 is the total dose for a 10 x 10 cm 2 field at that depth and A the field size 
in cm2. C2 (= 0.01194) and C3 (=0.9806) are averaged constants derived from the 
data for the lower set of curves in Figure 4.4. Fits to the data points were obtained 
with a non-linear least squares procedure (Marquardt, 1963) using Simplot. 
Moving across a 10 x 10 cm2 field yields only a minimal variation in radiation quality 
(Figure 4. 7) but beyond 5 cm displacements more dramatic changes are noted. To 
determine the relevance of measurements in the lateral plane, a modified dose profile 
was constructed using the appropriate weighting factors as follows: 
D. = D (y* I y* ) 
eff t l ca 
(3) 
Here Dt is the measured total dose as before, y; those values measured in the lateral 
plane and y* the y*-value on central axis, all measured at the same depth. Figure 
ca 
5.2 depicts the modified dose profile, constructed from data obtained at 10 cm depth 
in a 10 x 10 cm2 field. Only a slight broadening of the profile at the outer edges of 
the penumbra is apparent. The discrepancy between D· and Dt at these 
eff 
displacements is of little clinical consequence and quality change in the penumbra 
were thus not considered further. 
Neutron treatment planning 
Although the interaction mechanisms of photons and neutrons with tissue differ, the 
isodose distributions for the Faure therapy beam are very similar to those for 8 MV 
photons as regards depth dose and the shape of the build-up curve (Jones et al., 
1988). This permits the use of algorithms normally used in photon therapy planning 
for the calculation of two dimensional neutron isodose distributions (Vynckier et al., 
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modified effective dose D;ff 
(~) profiles obtained for the 
p{66}/Be{40) therapy beam in 
a 10 x 10 cm2 field at 10 cm 
depth in-phantom. 
1988). The computer planning system utilized at the N AC is the International 
General Electric Medical Systems, (Target 1) and employs the Bentley-Milan model 
for storage and data manipulation (Milan and Bentley, 1974) . The model requires 17 
equally spaced central axis ( cax) depth dose points, starting at the depth of 
maximum dose ( d ). Profile data at 5 equally spaced depths, with the first profile max 
at d , are also needed. These data are stored in fan line matrices with widths max 
chosen to enclose the 5% isodose lines at a depth of 10 cm. Cax and profile data are 
required for different field sizes as well as for different wedge and flattening filter 
combinations. These have been measured with tissue equivalent ionization chambers 
(Jones et al., 1988) and stored in a data file. In addition, output factors for the 
various square field sizes and wedge combinations are provided. Linear interpolation 
between measured data points is used to obtain cax and profile data for intermediate 
depths and field sizes. The planning system employs a third order power function to 
calculate relative doses in the build-up region and requires the surface dose value and 
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the dose at d 
max 
This method is satisfactory for the build-up region m most 
photon beams but not for the Faure neutron beam. Using a surface dose of 75% 
instead of the actual value (30%) gives good agreement between calculated and 
measured data, except for the first 5 mm of tissue where the physical dose is lower. 
This discrepancy does not usually present a problem as the dose gradient in the 
interval is too steep for the isodose lines to be resolved and only quality changes 
beyond D are considered here. 
max 
11reatment plan calculation 
Various parameters relevant to treatment planning have been investigated to identify 
those variables that give rise to significant variations in radiation quality. The depth 
dose and field size evaluations indicated a necessity to modify the total dose Dt by 
means of empirically derived expressions. As an illustration, the relationship given 
by equation 1 was applied to calculate a modified isodose distribution. Figure 5.3a 
depicts isodose curves generated for a single 10 x 10 cm2 field using depth dose curves 
determined with unmodified values (Dt) and adjusted values (Deff). As expected, 
discrepancies become more pronounced at greater depths. For two opposing fields 
(Figure 5.3b) larger differences are apparent at shallower depths. 
The overall effect that significant changes in beam quality will have upon external 
beam therapy is further illustrated by calculating the integral dose to a tumour 
volume. A 4-field plan to irradiate a symmetrically located 10 x 10 x 10 cm 3 tumour 
in the pelvic region was prepared (Figure 5.4). Total doses were used throughout as 
input data to the computer planning system to produce an optimized treatment plan. 
The maximum dose (hot spot) and the mean (prescribed) dose to the tumour volume, 
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( A)Isodose distribution generated for a 10 x 10 cm2 field using an 
unmodified depth dose curve (solid lines) and a Y*-weighted depth 
dose curve (broken lines). (BJ Isodose contours generated for two 
opposing 10 x 10 cm2 fields using an unmodified depth dose curve 
(solid lines) and a y*-weighted depth dose curve (broken lines). The 
unmodified isodose levels are indicated on the left-hand side of the 
diagram and the modified levels on the right-hand side. 
both expressed as a percentage, were calculated as 107 and 103, respectively. 
Modified depth dose data were then introduced using expression 1 and the plan 
recalculated. A value of unity was assumed for Csf . The modified plan yielded a 
maximum dose of 103% and a mean (effective) dose of 99%, the latter indicating a 
difference of 4% between prescribed dose and the effective dose delivered to the 
N 
" 
Figure 5.4 
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Optimal 4 -field treatment plan to irradiate a symmetrically located 10 
x 10 x 10 cm3 tumour in the pelvic region. Using physical doses as 
input data (black 'lines) y~elds a maximum and mean dose to the 
tumour of 1011/o and 103% respectively. The plan was recalculated 
introducing modified effective doses (red lines) and a maximum dose of 
103% and a mean dose of 99% were then obtained. 
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tumour volume. In instances where expression 2 is applied, slightly larger 
discrepancies are to be expected. 
Discussion 
In the application of neutrons to radiation therapy three aspects concerning radiation 
quality should be addressed. Firstly, the potency of the incident beam must be 
assessed by physical and radiobiological means. Secondly, intercomparison studies 
are required to establish a Clinical Neutron Intercomparison Factor ( CNIF) which 
converts the physical expression of dose into an effective or biological dose so that 
local clinical findings can be related to those observed at other centers (Wambersie 
and Battermann, 1987). Finally, where necessary, the spatial character of the beam 
within an irradiated phantom or patient needs to be evaluated. Here only the latter 
is examined. It has been shown that the effective dose along the central axis varies by 
6% over the depth range 2.5 cm to 20 cm and that the 4-field example indicates an 
ensuing 4% reduction in the dose to the tumour volume. The proposal for a 
comprehensive quality evaluation is only justified if it can be argued that these 
changes, which in this case are attributed to the neutron component in the beam, are 
of clinical significance. It is evident from the crypt cell assay of Bohm et al. (1990) 
that a change of at least 7% in the relative effectiveness of the beam will be manifest 
between 2.5 and 20 cm depths. For the crypt cells this indicates a Cs1 value > 1 in 
Equation 1. In the clinical situation where fractionated doses are delivered, the 4% 
discrepancy in the effective dose to the tumour volume can therefore be considered a 
conservative estimate. 
A report published by the ICRU in 1978 focused on two aspects of external beam 
therapy, namely the definition of the appropriate terminology and concepts, and 
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recommendations for reporting irradiations. This report is presently being revised to 
take account of new developments and changes that have occurred over the past 
decade. In a preview of the general trend followed in this revision the question of 
dose specification is addressed. The mean dose to the cancer cell population is 
identified as having greater bearing on tumour response than either the absorbed dose 
at a specified point or dose homogeneity throughout the tumour volume {Wambersie, 
1990). The present study shows that by disregarding quality changes in the 
irradiated volume, an error of at least 4% is introduced where considerations for 
optimum therapy are the most critical. The quality evaluation demonstrates that the 
3.5% accuracy goal set by Mijnheer et al. (1987a) for the dose at a specified point in 
the patient is exceeded by a factor of almost two over the depth range 2 to 20 cm. 
It is not suggested here that doses to the tumour volume be increased in all instances 
where effective doses at depth are significantly less than the prescribed physical dose. 
The investigation does, however, show that when CNIFs are determined, quality 
evaluations within a phantom could be of assistance in arriving at an optimum dose 
to the tumour. Dosimetric and radiobiological data acquired in two p/Be beams 
generated at similar proton energies but characterized by different soft neutron 
components, must be treated with caution when performing dose-finding studies for 
tumour control and normal tissue tolerance at depth. 
Compared to absorbed dose measurements with ionization chambers, TEPC 
observations demand a more sophisticated data acquisition system and data analysis 
is more complex. For this reason microdosimetric techniques are not part of the 
conventional instrumentation employed at neutron facilities for dose assessments. 
Single event spectra have, however, been measured at several centers {Pihet et al., 
1989) and although these surveys may not be fully comprehensive, sufficient data 
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exist for a reassessment of the depth dose information at selected centers. Moreover, 
much radiobiological data has been acquired at many of these centers. Where such 
data are available, the sensitivity factor Csf can be estimated with greater accuracy. 
Clearly the product C C f is central to the argument for quality changes along central 
I S 
axis and would render the depth dose expression superfluous should it approach zero. 
This work has shown that for a p(66)/Be(40) therapy beam the product CC f is large 
I S 
enough to warrant the recalculation of selected treatment plans. The need to account 
for quality variations associated with different field sizes between 30 cm2 and 200 cm2 
is also apparent. In each instance simple expressions have been formulated to modify 
total dose values that have been measured by conventional means, that is with a TE 
ionization chamber. Unless indicated to the contrary, these expressions could in 
principle, find general application to similarly generated p/Be neutron beams. The 
significance of single event spectra is further enhanced when TEPC measurements are 
applied to intercomparison studies (Menzel et al., 1990; Pihet et al., 1990b) in which 
the problem of non-uniformity between different neutron beams is addressed and a 
method proposed to minimize the error associated with CNIF-values. The 
uncertainties surrounding neutron kerma in the 20-65 MeV energy range have yet to 
be resolved and could well prove to be larger than the dose discrepancies indicated in 
this study. Kerma factor uncertainties do not, however, detract from the findings of 
this work nor that of Menzel et al. (1990) and Pihet et al. (1990b). For the new 
generation of neutron beams, consideration should be given to beam quality within 
the patient. This could contribute to the optimization of the dose to the tumour 
volume and thereby enhance the efficacy of fast neutron therapy. 

CHAPTER 6 
TIME-RESOLVED MICRODOSIMETRY 
Introduction 
In the application of fast neutrons to radiation therapy there is a growing awareness 
of the need for more comprehensive nuclear data. This is highlighted by the 
requirement to accurately measure absorbed doses in neutron therapy beams which 
have a broad energy spectrum extending up to 65 MeV. Prospective clinical trials are 
currently underway at a number of neutron facilities and comparisons with 
conventional photon modalities are demanded. In these instances the overall 
uncertainty in the measured absorbed dose becomes important. For irradiation 
prescriptions to be equivalent and thus comparable, the accuracy in the absorbed 
doses administered for each modality needs to be similar and within certain specified 
bounds. These limits have been quantified in an earlier review (Mijnheer et al., 
1987a) and the overall uncertainty in the dose for high energy neutrons was estimated 
to be approximately 8%, nearly twice that of their photon counterparts. 
In neutron absorbed dose measurements the single largest source of error derives from 
the lack of tissue equivalence for the wall material used in the construction of neutron 
dosimeters. The walls of these ionization chambers are made from Shonka A-150 
plastic which was originally designed to be tissue equivalent for photons. Table 6.1 
compares the elemental composition of tissue with that of A-150 plastic and shows 
how the proportions of carbon and oxygen in tissue are approximately reversed in 
A-150 plastic. The carbon content makes the plastic electrically conducting and 
suitable for use in the construction of ionization chambers where a potential gradient 
needs to be maintained between the anode (collecting electrode) and cathode (wall). 
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A solid conductor with the proper amounts of hydrogen and oxygen matching those of 
tissue has not been found. 
Table 6.1 Elemental composition of tissue and Shonka A-150 plastic in 
percentages by weight (ICRU, 1983}. 
H C 0 N Ca F 
ICRU tissue 10.2 12.3 72.9 3.5 0.007 
A-150 plastic 10.1 77.6 5.2 3.5 1.8 1. 7 
To account for any dose discrepancies that may occur due to differences in the 
elemental composition of tissue and A-150 plastic a correction factor is applied. This 
factor is given by the ratio of the neutron kerma factors, that is, the kerma per unit 
neutron fluence for the respective materials. Kerma factors vary with energy and 
values spanning the entire energy range of the therapy beams in question are 
therefore needed. Below 20 MeV kerma factors for A-150 plastic and its main 
constituents hydrogen and carbon are well known as the relevant nuclear cross section 
data are available and direct integral measurements have been performed (DeLuca et 
al. 1984; Menzel et al., 1984; DeLuca et al., 1986; Pihet et al., 1992b). At higher 
neutron energies however, the nuclear data required for kerma factor evaluations are 
scarce and nuclear model calculations do not provide reliable predictions. As energies 
increase the problem is exacerbated as more reaction channels become possible, the 
probabilities of which are unknown. 
Kerma 
A pragmatic approach is to measure the kerma factors directly and for this the kerma 
at a particular energy is required. Kerma can in principle be measured for A-150 
plastic but not for tissue, where instead the result needs to be synthesised from data 
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for each of the elemental constituents. At energies below 20 MeV direct assessment 
of kerma is possible in specially generated monoenergetic neutron fields using 
spherical proportional counters with walls manufactured from the material of interest 
(DeLuca et al., 1984; Menzel et al., 1984; Buhler et al., 1986; Wuu and Milavickas, 
1987; Pihet et al., 1992b ). At higher energies pure monoenergetic fields cannot be 
produced and only quasi-monoenergetic fields are available where the principal 
energy peak is accompanied by a large low energy tail. Events from these low energy 
neutrons will be registered by a proportional counter and an additional kerma not 
associated with neutrons of the nominal energy will be included in the measured 
response. This spurious kerma can constitute a large proportion of the measured 
kerma ( typically 40-50%) and independent measurements are then necessary to try 
and quantify the additional contribution (Schuhmacher et al., 1992). 
Time-of-flight 
An alternative approach is to apply time-of-flight (TOF) techniques where event 
registration is related to the neutron time of arrival at the detector. In this way it is 
possible to discriminate against the unwanted events due to slower, low energy 
neutrons. The timing response of proportional counters operating at low gas 
pressures is however poor and not suited to TOF because the signal pulses produced 
have large variations in shape (rise time) and height (magnitude). Measurements 
with a 1/2-inch spherical TEPC have been performed in monoenergetic beams of 
low neutron energy (En = 50 keV) where it proved impossible to obtain a simple 
separation of the photon-neutron fraction by defining a linear gate on the TOF 
spectrum (Schrewe et al., 1988a). The inferior timing characteristics observed with 
these counters are due to both inherent and extrinsic effects. Of particular 
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importance are the drift times required by free electrons to travel from the site of the 
original ionization in the cavity to the anode. Significant also is the problem of 
amplitude walk, which derives from the manner in which the timing pick-off device 
accommodates the large dynamic range of pulse heights associated with energy 
depositions inside the counter. 
Recently the phenomenon of electron drift times was investigated and improvements 
made by changing to an isobutane-based TE gas mixture (Schrewe et al., 1989) and 
reducing the effective volume of the counter by operating it in the so---called 1'hdix" 
mode. This is achieved by applying a negative bias to the helical wire surrounding 
the anode and thereby restricting the sensitive volume of the counter to a small 
cylinder concentric with the anode (Schrewe et al., 1990). This arrangement 
demonstrated an apparent timing response of 20 ns (FWHM) but would still be 
inadequate when detecting 63 MeV neutrons over a 6 m flight path. During the 20 ns 
time interval neutrons with energies extending down to 33 MeV would have arrived 
at the counter. No helix mode single event distributions were presented by the 
authors and it is not clear if the quoted timing response is that for the full dynamic 
range of pulse heights encountered in the fast neutron microdose distribution. A 
better timing response of 14 ns has been reported by Randers-Pehrson et al. (1983) 
where microdose distributions are shown. However, their results were obtained not 
using a commercial TEPC but with a custom built, small cylindrical counter of 
wall-less design where difficulty was experienced in calibrating the pulse height data. 
In neither of these studies was sufficient consideration given to the deleterious effects 
of amplitude walk on the observed timing response of the TEPC. 
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Present study 
The purpose of this investigation is to demonstrate that TOF spectrometry in a high 
energy neutron field is possible with a commercial Rossi counter operating in helix 
mode. This necessitated a study of the intrinsic performance of the counter and other 
external factors associated with time pick---off. To optimise both pulse height and 
timing resolutions over the full range of event sizes contributing to the microdose 
distribution, suitable voltages for the anode and helix were required. Reliable dose 
distributions with discernible detail were successfully obtained in helix mode (Binns 
et al., 1992) and the reduced sensitive volume determined by exposing the counter to 
a known neutron dose. The improved timing characteristics exhibited by this 
detector geometry were examined as a function of pulse height to reveal the inherent 
timing capabilities of the detector. 
Materials and Methods 
Pulse height resolution was studied by collecting single parameter event size 
distributions using the conventional data acquisition system described in Chapter 2. 
A 1/2-inch spherical Rossi-type TEPC with a wall thickness of 2.5 mm was filled 
with the isobutane based TE gas mixture (partial pressures of 51.4% C 4H 10 , 42.3% 
CO2 and 6.3% N 2) proposed by Schrewe et al. (1989). The elemental composition of 
this mixture is very similar to that of the propane based TE gas (Srdoc, 1970) and is 
given in Table 6.2. Filling the counter to a pressure of 7.6 kPa simulated a 2µm 
diameter sphere of unit density tissue when operating in normal mode with the 
conventional voltage configuration. 
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Table 6.2 Elemental composition of tissue equivalent gas mixtures in 
percentages by weight. 
TE Mixture H C N 0 
Propane based 
(Srdoc, 1970) 10.3 56.9 3.5 29.3 
Isobutane based 
(Schrewe et al., 1989) 10.3 59.2 3.5 26.9 
Microdose distributions were obtained by operating the TEPC in both normal and 
helix modes in two well defined neutron fields of widely differing energies. As a test 
of pulse height resolution over a broad range of lineal energies, in--air measurements 
were performed in the p(66)/Be(40) neutron therapy beam of the NAC at an SAD of 
150 cm and in a 10 x 10 cm2 field. The 2.5 mm thick walled TEPC was irradiated 
with and without additional build-up provided by a TE cap of wall thickness 16 mm 
placed over the aluminium housing of the detector. Integrated charge from a 
transmission chamber located downstream from the target in the collimator head 
assembly served as beam monitor. 
To determine the sensitive volume associated with the helix geometry the TEPC was 
exposed to monoenergetic neutrons of energy 2.3 MeV as the microdose distribution 
for this source exhibits a pronounced and easily discernible proton edge. The 
neutrons were generated via the T(p,n)3He reaction with 3.1 MeV protons from the 
Van de Graaff accelerator. Exposures were made in a scatter-free area with the 
counter positioned in-air at Q° and at a distance of 20 cm from the geometric centre 
of the tritium gas cell. During these measurements the integrated charge on the 
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target was used as a beam monitor for the exposures. 
The timing characteristics of the commercial proportional counters were studied in a 
pulsed neutron beam at the neutron time--0f-flight facility described in Chapter 3. A 
quasi-monoenergetic neutron field with a principal peak energy of 62.6 ±0.85 MeV 
was produced by bombarding a 1.1 mm thick Be target with protons of energy 65.3 
±0.2 MeV. The Q-value for the 9Be(p,n)9B reaction is -1.85 MeV (Ajzenberg-
Selove, 1984) and a maximum energy loss of 1.70 MeV was calculated for the incident 
protons using the stopping power data of Andersen and Ziegler (1977). Separate 
measurements using the TEPC and CPC were performed with the detectors 
irradiated free in-air. In each instance full secondary charged particle equilibrium 
was ensured by placing customized build-up caps of the appropriate material and 
thickness over the aluminium housing of the detectors. Wall thicknesses of the TE 
and carbon (graphite) caps were 32 and 16 mm respectively. The CPC was similarly 
filled with the isobutane--based TE gas mixture at a pressure of 7.6 kPa. The 
detectors were positioned at a distance of 6 m from the target and orientated with the 
anode perpendicular to the incident beam direction. The spread in the neutron TOF 
at this distance was characterised with a neutron spectrometry system utilizing a 
5 cm x 5 cm NE213 liquid scintillator that has been described previously (Binns and 
Hough, 1987). 
Electronic System 
To enable investigation of the timing response of the proportional counters data were 
acquired in multi-parameter mode. Each pulse height event registered by the 
counter is chronicled by its own TOF relative to the cyclotron RF. A schematic 
diagram of the electronic system used for pulse processing and data acquisition is 
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shown in Figure 6 .1. The electronics for the three linear legs that convey the single 
event pulse height information are the same as previously described ( Chapter 2) 
except that a delay module and a linear gate and stretcher (LGS) are inserted 
between each linear amplifier and the fast ADC ( 450 MHz clock rate). In addition 
there is a fast timing circuit that generates a start signal for the time-to-amplitude 
converter (TAC). To optimize time pick--0ff, an amplitude and rise time 
compensated timing unit (ARC) was employed. The ARC timer is designed to 
extract timing information from detectors that generate a wide range of pulse rise 
times. This is achieved by basing the timing signal on a fixed fraction of the initial 
portion of the pulse, negating the effect of any shape changes that may occur at a 
later time in the waveform (Chase, 1968). Otherwise the module works similarly to a 
constant fraction discriminator using a zero crossing technique of a synthesised pulse 
Figure 6.1 
C V A A M X M 
A B 7 
C D s 
0 
~ ONLIN~ TEAM • 
Block diagram of the electronic system used for pulse processing and 
multi-parameter data acquisition. Index. ADC = analogue to 
digital converter-, AMP = spectroscopy amplifier-, ARC = 
amplitude and rise time compensated timing module; BPO = beam 
pick-off, DISC= 100 MHz discriminator-, DLY = delay; GDG = 
gate and delay generator-, HV = high voltage supply; LGS = linear 
gate and stretcher-, MAG TAPE= magnetic tape drive; MBD = 
microprogrammed branch driver-, ONLINE TERM = on-line 
terminal; PA = preamplifier-, PULSER = pulse generator-, TAC 
= time-to-amplitude converter-, TEPC = tissue equi1Jalent 
proportional counter-, UCO = universal coincidence. 
to minimise timing errors caused by large fluctuations in the pulse height of the 
detector signals. The stop pulse for the TAC is provided by a delayed beam pick--0ff 
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(BPO) from the pulse selector of the cyclotron. The sequence of start/stop signals 
helps to minimise electronic dead time and results in a time reversal of the TOF 
spectrum. 
Two outputs are furnished by the TAC. The time to pulse height conversion 
(TPHC) signal is an analogue output pulse proportional to the measured time 
interval between successive start and stop inputs and represents the TOF spectrum of 
all events registered from the detector. This is recorded as a separate pulse height 
parameter. The built-in single channel analyser (SCA) generates a logic output 
which is used to gate the four analogue signals of interest and provides the event 
trigger. The latter is a signal that indicates to the data acquisition system that an 
event has occurred and that the ADCs should be read out. The circuitry providing 
the event trigger and computer busy signals are shown separately in Figure 6.2 for 
clarity. The event trigger signal is sent to the CAMAC event trigger module which 
then initiates the event read-out cycle of the data acquisition process. During the 
read-out cycle a computer busy signal is generated ( duration N40 µs) that inhibits the 
gates on the LGS modules. The event rate was low (30 cps) and the overall electronic 
and computer dead times were considered negligible. 
UCO 
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Block diagram of the event trigger and computer busy signals 
omitted from Figure 6.1. Index. DISC = quad discriminator-, 
EVENT TRIG = event trigger module; FAN = logic fan-in/ fan-out; GDG = gate and delay generator-, LEVEL = level 
adaptor-, MBD = microprogrammed branch driver-, UCO = 
universal coincidence. 
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The proton beam current on the Faraday cup located in the beam dump was 
measured using a Brookhaven Instruments current integrator (BIC model lOOOC). 
This instrument generates digital output pulses (5 µ.s width) with a frequency 
proportional to the accumulated charge. The various parameter settings are fed to 
the CAMAC current integrator module which in turn are recorded by the data 
acquisition system. The proton beam current was monitored throughout. 
Computer interface 
The electronic signal processing equipment is interfaced to the data acquisition 
computer by means of CAMAC (Computer Automated Measurements and Control). 
The digitised output from each of the ADCs is fed to a CAMAC interface module of 
in-house design. This module ensures complete control ( enable, disable and clear) 
and the digitised data is read over the CAMAC dataway as a 16-bit word. The four 
ADC interface modules were slotted into a CAMAC crate containing a LeCroy 2551 
CAMAC 12-fold scaler, CAMAC event trigger module and the current integrator 
status read-out module. 
Data acquisition 
The computer facility serving the experimental data room where the electronic 
modules are configured consists of two computers, namely a V AX-11/730 dedicated 
to on-line data acquisition and a V AX-11/750 used for off-line data analysis and 
general computing tasks. The computers are linked to one another via an Ethernet 
network and supplemented with magnetic tape drives. The interface between the 
VAX-11/730 and the CAMAC crate is a Bi-Ra microprogrammed branch driver 
(MBD-11). A full description of the computer hardware is given by Pilcher (1989). 
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During a run all events are recorded on magnetic tape ( 6250 bpi) on an event-by-
event basis. This permits the experiment to be replayed and allows for timing 
corrections and the imposition of any software generated gates that may be desired in 
the off-line analysis. An on-line graphics terminal provided colour screen monitoring 
of recorded spectra. 
Computer software 
Data acquisition and subsequent off-line analysis were performed using the software 
package XSYS, the origins and structure of which are described elsewhere (Pilcher, 
1989). Prior to the commencement of data acquisition the computer software is set 
up rn three stages as follows: XSYS is initialised, followed by an allocation of 
computer memory to hold the required number of histograms (spectra) and gates. 
Thereafter the Data Acquisition Program is implemented and the Event Analysis 
Language (EVAL) code loaded. 
Memory allocation 
Global memory of 4800 pages ( 1 page = 512 bytes) was required for each 
experimental run ( and replay) and a list of the histograms and gates used during data 
acquisition is given in Table 6.3. Data areas of 1024 channels were allocated to each 
of the three pulse height spectra (single event frequency distributions). The TOF 
parameter for all output events from the detector were recorded in a fourth 
one-<limensional data area of 512 channels. Three two-<limensional data areas of 
TOF (256 channels) versus pulse height (512 channels) were created to study the 
TOF spectra for each amplification stage. One-<limensional projections (512 
channels) onto the TOF axis of data bound by linear gates set at different pulse 
heights were also possible. All data areas could be viewed on-line. 
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Table 6.3 List of histograms and gates for data acquisition. 
Number of Size of Contents 
histograms histograms 
(channels) 
3 1024 Histograms of pulse height events 
1 512 Histogram of TOF spectrum 
3 512 1-D projections of time spectra for 
gated pulse heights 
3 512 X 256 2-D TOF vs pulse height 
3 - 1-D gates for pulse height data 
Data Acquisition Program {DAP) 
The actual data acquisition was controlled by a sorting subprocess of XSYS called 
XSORT which reads both the Data Acquisition Program (DAP) and the Event 
Analysis Language (EVAL) files. The necessary CAMAC commands required by the 
branch driver (MBD) for crate initialisation, starting and stopping runs and for 
individual event reading were contained in the DAP file. Data were read 
event-by--€ven t. 
Event Analysis Language (EVAL) 
The EV AL code controlled the incrementing of the histograms and operates by 
analysing the data on an event-by--€vent basis. Procedures such as gate setting 
requirements, simple arithmetic and logical manipulations (FORTRAN code may be 
called by the lower level EV AL) were included. 
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Results 
Pulse height response in helix mode 
Voltage settings with respect to the grounded wall of 480 V (anode) and -100 V 
(helix) produced the most promising time spectrum overall (see Timing response in 
helix mode and voltage optimization). To assess the feasibility of helix mode 
operation using this voltage combination, the resultant gas gain and pulse height 
resolution were examined in a high energy neutron beam. 
Single event spectra were collected at the N AC neutron therapy facility where a well 
characterised source of fast neutrons was available (Binns and Hough, 1988). The 
pulse height information was recorded in single parameter form using the 
conventional data acquisition system. Figure 6.3 illustrates the similarity of dose 
distributions obtained with the TEPC when running at the optimum voltages in both 
helix ( 480 V /-100 V) and normal (590V /118V) modes. These lineal energy spectra 
were measured in-air and with full build-up and have not been extrapolated to lower 
lineal energies. To aid comparison the proton edges of the two spectra have been 
aligned and it can be seen that the dynamic ranges of the event sizes are comparable. 
Similar features associated with the different particle species emitted from the 
counter wall can be identified in both spectra but with the helix mode having a 
broader fast proton peak and less sharp edges associated with the slow proton and 
alpha components. In helix mode the active volume is restricted to an elongated 
cylinder concentric with the anode (Schrewe et al., 1990) and contrasts in the 
character of the helix microdose spectrum are attributed to differences between the 
chord length distributions for an elongated cylinder and a sphere. The less 
pronounced cut-Dff edges for the proton and alpha components are in agreement with 
calculations for elongated or oblate cylinders (Birkoff et al., 1970) 
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When measuring in helix mode at the chosen voltage settings, the data show that 
there is sufficient gas gain to provide the necessary charge amplification for the wide 
range of event sizes produced inside the sensitive volume . An adequate pulse height 
resolution is also realized over the extended range of lineal energies encountered in 
the 66 MeV proton generated neutron field . 
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Figure 6.3 Lineal energy 
spectra measured in-air with 
full build-up in the 
p( 66)/ Be(40) therapy beam . 
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The negative bias on the helix in combination with the anode voltage govern the size 
of the sensitive volume when operating in helix mode. Verification of the exact size 
of the sensitive volume is needed to assess kerma from the single event spectra 
measured in helix mode, and in particular it was necessary to quantify the mass of 
gas (m) and the associated mean chord length (l) for the assimilated volume. In a 
first approximation the active volume was assumed to be contained in an elongated 
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cylinder concentric with the anode, for which the mean chord length l is given by the 
Cauchy relationship 
2rh 
r+n (6.1) 
where r is the radius and h the height of the cylinder (ICRU, 1983). This relationship 
assumes an isotropic irradiation of the cylinder within the spherical volume. 
Figure 6.4 depicts equivalent spectra measured in the 2.3 MeV neutron beam with the 
TEPC operating in normal and helix modes. A correspondence between the 
distributions is again evident with the proton edge clearly discernible. This edge 
results from the maximum possible energy deposition by a proton inside the gas 
cavity of the counter and arises from a traversal of the longest chord length inside the 
sensitive volume of the detector. This path length and hence the energy loss is the 
same for both the sphere and cylinder (i.e. 2µm) and the correct position for the edge 
in terms of lineal energy depends only upon the effective mean chord lengths for the 
different geometries. 
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Figure 6.4 Single event spectra 
measured with the TEPC 
in a 2. 3 Me V mono energetic 
neutron field with the counter 
operating in normal ( - - - ) and 
helix (--) modes. The 
proton edges are positioned 
according to the values detailed 
in Table 6. 5. 
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The dose per monitor count was determined from the normal mode measurement 
after positioning the proton edge of the single event spectrum at a lineal energy of 
135 ke V µm -1. The spectrum measured in helix mode was then adjusted by adopting 
a particular elongation, keeping the length of maximum traversal constant, and then 
calculating the corresponding volume and mean chord length. By placing the proton 
edge in the appropriate lineal energy bin for each assumed elongation or volume, an 
absorbed dose per monitor count was obtained and compared with that determined in 
normal mode. The largest uncertainty associated with this procedure was positioning 
the proton edge in the designated lineal energy bin of finite width. Moving the edge 
of the normal mode spectrum by one bin induced a change in the measured absorbed 
dose of 5.6% and this figure was considered as a conservative estimate of the 
uncertainty in deducing the sensitive volume in helix mode. Table 6.4 lists the 
various values used to obtain the curve depicted in Figure 6.5 from which the unique 
mean chord length ( and thus the cylinder volume) was determined. 
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Table 6.4 Mean chord lenfth (l), volume (VJ and maximum lineal energy for 
protons (y calculated for cylinders with different elongation (E) p,max 
inside a 2 µm spherical cavity. 
E l V Y p,max Dhelix 
(µm) (mm3) (keV µm-1) Dnormal 
4.50 0.391 74 460 1.37 
4.25 0.411 82 438 1.23 
4.00 0.427 92 422 1.06 
3.75 0.458 104 393 0.95 
3.50 0.473 116 381 0.83 
3.25 0.504 133 357 0. 73 
Initial estimates of the radius and hence elongation (ratio of height to diameter) of 
the cylinder were based upon the reported diameter of 3.2 mm for the helical 
electrode (Oliver et al., 1972). The effective diameter of the sensitive volume in helix 
mode was found to be 3.2 mm. An X-ray inspection of the counter and subsequent 
enquiry with the manufacturers confirmed that the actual diameter of the helix was 
only 0.8 mm. The extension of the sensitive volume beyond the physical boundary 
defined by the helix is attributed to a complex pattern of electric field potentials 
created between the anode, helix and wall. A summary of the parameters describing 
the assimilated volume is given in Table 6.5 together with that for the normal 
sphere. The correct positions on the lineal energy scale for the proton (y ) and 
p,max 
alpha (y ) edges were calculated using the accepted energy loss values O:,max 
t:.Ep (protons) and t:.E a (alphas) for propane based TE gas (Pihet and Menzel, 1989; 
Schrewe et al., 1988b). Calculations performed comparing the isobutane and propane 
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based mixtures indicated energy losses differing by only 0.6% which was not 
considered significant. 
Table 6.5 Definition of sensitive volumes in normal and helix modes. 
.----------------------
---·-
Geometry 
Volume (mm3) 
Mass (mg) 
Elongation 
Mean chord length (µm) 
Maximum traversal (µm) 
6.E (keV) p 
6.E (keV) 
a 
y (keV µm-t) 
p,max 
y (keV µm-t) 
a,max 
Spectra calibration 
NORMAL 
Sphere 
1033 
162.7 
1 
1.33 
2 
180 
526 
135 
395 
HELIX 
Cylinder 
97 
15.3 
3.9 
0.44 
2 
180 
526 
409 
1195 
To establish whether calibration of helix pulse height spectra was practicable in 
neutron beams where the cut-off edges are less pronounced, irradiations were 
performed in the therapy beam under strict dosimetric conditions. Figure 6.6 shows 
unextrapolated microdose distributions measured in the two different modes at the 
NAC neutron therapy facility. The measurements were carried out in a 10 x 10 cm2 
field at an SAD of 150 cm with the detector free in-air. As a further test of helix 
mode additional build-up was deliberately omitted in order to produce subtly 
different microdose spectra from those previously measured (Figure 6.3). The wall 
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thickness of 2.5 mm was sufficient to achieve 78% of the full dose build-up. Both 
dose normalised spectra exhibit reduced fast proton dose components compared with 
those measured at full build-up with the helix mode again reproducing the 
characteristic features of the normal mode measurement . 
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Figure 6.6 Dose normalised 
micrndose distributions 
obtained in the p( 66)/ Be(40) 
therapy beam with the T EPC 
operating in normal ( - - - ) and 
helix (-) modes. 
Irradiations were performed 
in-air without additional 
build-up and the spectra were 
calibrated using the proton 
edge method . 
Spectra were calibrated by positioning the respective proton edges according to the 
values detailed in Table 6.5 and the dose (in A-150 plastic) per monitor count was 
obtained with an overall uncertainty of approximately 8.2% (see Chapter 2). Prior to 
data collection the transmission chamber serving as beam monitor was calibrated 
against measurements using TE ionization chambers with full build-up. This 
practice is adopted at the NA C where the dosimetry protocol of Mijnheer et al. 
(1987b) is applied. The calibrated dose (in A-150 plastic) per monitor count was 
then corrected by 0. 78 to allow for the lack of build-up during the microdose 
measurements. An uncertainty of 4.7% is associated with the absorbed dose 
determination to the A-150 wall of an ionization chamber when the tissue/ A-150 
kerma ratio is not applied (Broerse et al., 1981). 
Extrapolating the normal mode spectra to lower lineal energies increased the 
measured dose by 0.3% and gave a dose per monitor count that concurred with the 
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calibration value. The dose from the helix mode spectrum differed by only 1 %, well 
within the estimated experimental uncertainties. 
Table 6.6 Comparison of average microdosimetric values obtained in normal and 
helix modes. 
NORMAL HELIX 
yF (keVµm-1) 7.24 16.40 
Yo (keV µm-1) 90.9 262.6 
EF (keV) 9.64 7.22 
ED (keV) 120.9 115.5 
Average values for the microdosimetric parameters y F and y D were determined for 
the two different volumes from the calibrated spectra and are presented in Table 6.6. 
To facilitate a direct comparison between the two modes the average values were 
multiplied by the appropriate mean chord lengths to obtain the mean energy 
imparted per event ED and the frequency mean energy imparted, EF. Assuming 
uncertainties of 10% and 6% in the experimental determination of y F and y D 
respectively (Waker, 1985), the ED values appear to correspond whereas the EF values 
differ significantly. This is in agreement with theory evaluating the equivalence of 
spherical and cylindrical volumes (Kellerer, 1981). 
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Time-of-flight 
The TOF spectrum measured in the quasi-monoenergetic neutron beam with the 
NE213 liquid scintillator is presented in Figure 6. 7. This detector is sensitive to both 
neutrons and photons and possesses good timing properties allowing distinct features 
to be discerned. Events in the time spectrum due to neutrons of nominal energy 
62.6 MeV are identified by the sharp peak (FWHM = 3.8 ns) which predominates, 
followed by the continuous low energy tail resulting from nuclear break-up. During 
this measurement the pulse shape discrimination ( n-1 identification) was set to allow 
a portion of the gamma events to be registered. The attendant gamma component is 
emitted in proton induced reactions in the Be target and precedes the primary 
neutron peak by 35 ns. The TOF spectrum was calibrated to a nanosecond scale by 
altering the delay between the start and stop pulses. The spectrum shift produced by 
the use of standard 50 and 100 ns delay line boxes yielded a time calibration of 
0.38 ns per channel. In a TOF measurement the velocity v of a neutron of mass m is 
determined by the time t it takes to travel a distance L and can be calculated from 
the equation for kinetic energy 
1 1 En = 2 mv2 = 2 m(L/t )2 
which in the non-relativistic case simplifies to 
t = 72.3 L (En)-1/ 2 (ns) 
where L is expressed in metres and En in Me V. 
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Figure 6.7 TOF spectrum 
measured over a 6 m flight 
75 - _ path for the NE 213 liquid 
V> scintillator m the 62.6 MeV ...... 
C quasi-mono energetic neutron :::, 0 
u field. Events due to neutrons 
Q) 50 -
- of the nominal energy are 
.2:'. 
...... identified by the sharp peak D 
Q) (FWHM - 3.8 ns) which O'.'. 
25-
- predominates. The attendant 
gamma component is seen 
preceding the primary peak by 
0 A 35 ns. I I 
300 200 100 0 
Time of flight (ns) 
Timing response in helix mode and voltage optimization 
When operating in helix mode an appropriate choice of voltages for the anode and 
helix was carefully considered. Arcing limited the voltage differential to 600 V and a 
series of voltage combinations was tested for timing resolution and gas gain. For the 
initial investigations of the timing response beamtime scheduling constraints did not 
permit setting up and tuning of the complete system {Fig. 6.1) and full multi-
parameter data collection was not possible for the preliminary investigations of the 
timing response. Instead the TPHC output from the TAC was stored as single 
parameter data on an MCA and the detector pulses observed on an oscilloscope. As 
the pulse height information was not being retained in this instance, the rise time 
reject discriminator (a O to 10 turn potentiometer) on the ARC timer was set at 4.0. 
This excluded from the TOF spectra those small pulse height events expected to 
cause time slewing that would mask the true timing response from the TPHC output. 
Figure 6.8 shows the results of TOF spectra measured with the TEPC operating at 
various applied bias settings. Initially the counter was operated with no voltage 
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applied to the helix and the anode voltage reduced to 528 V with respect to the 
grounded wall (Fig. 6.8a). This provided the same gas gain, measured with the 
internal calibration source, as when operating in normal mode. The TOF spectrum 
for this voltage setting is a broad single peak (FWHM = 61 ns) with no discernible 
detail. The slow inherent response is attributed to the time variations in pulse 
formation depending upon where the original ionization occurs within the spherical 
volume of the detector. Due to the different drift times required by the electrons to 
reach the collecting wire, events distant to the anode form pulses that are delayed in 
time relative to those occurring nearby which obscures the TOF information and 
produces a poorly resolved timing spectrum. 
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TOF spectra measured over a 6 m flightpath with the TEPC 
operating at various applied bias settings in the 62. 6 Me V 
quasi-monoenergetic neutron field. In this representation the 
abscissa scales are reversed. The voltages to the anode and helix 
were respectively (a) 528,0; (b) 480, -50; (c) 480, -100; (d) 380, 
-100. 
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To reduce the size of the sensitive volume a negative voltage of -50 V was applied to 
the helix with the anode bias accordingly reduced to 480 V so as to maintain a similar 
differential of approximately 528 V with the wall again being held at ground 
potential. An improved timing response was apparent with the expected general form 
of a peak of nearly monoenergetic neutron events (FWHM = 21 ns) followed by a 
long low energy tail starting to become evident (Fig. 6.8b ). Altering the helix voltage 
to -100 V appeared to improve still further the form of the TOF spectrum (Fig. 6.8c) 
although the actual width of the 'monoenergetic' peak appeared similar (FWHM = 22 
ns). The combination used by Schrewe et al. (1990) of 280 V (anode) and -200 
V (helix) was also applied but resulted in a very poor gas gain which was considered 
unacceptable. Measurements were however performed at a similar voltage differential 
( 480 V) with settings of 380 V and -100 V for the anode and helix respectively but 
also resulted in a low gas gain (Fig. 6.8d). 
The correlation between the timing performance of a TEPC and size of the detector 
has been demonstrated previously where a small cylindrical detector of 0.8 mm radius 
(Dicello, 1983) showed a measured timing response of 14 ns (FWHM) compared to 
that of 75 ns (FWHM) for a 6.4 mm radius sphere (Randers-Pehrson et al., 1983). 
TO F in helix mode 
Timing characteristics of the 480 V (anode) and -100 V (helix) voltage combination 
were investigated in detail using multi-parameter data collection and without an 
artificially high setting on the discriminator of the time pick-off. The threshold was 
adjusted to include small pulse height events in the timing spectrum and was set just 
above the electronic noise level of the detection system ( N 0.6 m V). Figure 6.9 shows 
a comparison of TOF spectra obtained in the 62.6 MeV quasi-monoenergetic neutron 
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beam when operating the TEPC in normal and helix modes together with the 
spectrum from the NE213 detector. These TEPC distributions are composite TOF 
spectra encompassing the timing for the entire range of detector pulses. 
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Figure 6.9 Comparison of 
TOF spectra measured over a 
6 m flightpath in the 62. 6 Me V 
quasi-monoenergetic neutron 
field. TEPC operating in 
normal mode (---), FWHM 
= 73 ns; TEPC operating in 
helix mode (-), FWHM = 
21 ns; NE213 liquid scintillator 
( · · · ), FWHM = 3.8 ns . 
The almost featureless asymmetric distribution (FWHM = 73 ns) for the 
conventionally operated TEPC is comparable in shape and width (FWHM = 75 ns) 
to that reported for a 20 MeV monoenergetic neutron beam (Randers-Pehrson et al., 
1983) and conveys little useful information about the character of the neutron beam. 
A distinctly narrower (FWHM = 21 ns) but still unstructured distribution was 
evident when operating the counter in helix mode where the assumed active volume is 
reduced to a cylinder surrounding the anode. The apparent loss of character for this 
helix measurement compared to the preliminary TOF spectrum obtained with the 
same voltage settings (Fig. 6.8c) is attributed to the lower discriminator setting on 
the ARC timer. 
Amplitude walk ( time slewing) 
Following optimization of the intrinsic operation of the TEPC, the possible influence 
of external factors on the observed timing response was investigated. In particular 
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the effect of amplitude walk concomitant with time pick-off, derived from input 
pulses of variable amplitude as encountered in microdosimetry and hitherto ignored, 
was examined. The data for each amplifier stage were therefore inspected separately. 
Figure 6.10 depicts two-dimensional density plots of TOF relative to pulse height 
data collected in the three amplification stages (XlO, XlOO, XlOOO). Scrutiny of the 
data in the medium gain amplifier (XlOO) showed two clusters or groups of data 
associated with photons and neutrons emanating from the target and properly 
separated in time. Clear separation between the two dose components has not been 
reported before in TOF studies with low pressure proportional counters and is 
indicative of the excellent overall performance of the counter. The characteristic 
curvature to the leading edge of each group becomes more pronounced at lower pulse 
heights and can be ascribed to amplitude walk or time slewing. 
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Figure 6 .10 Tw<rdimensional 
density plots correlating pulse 
~ height events processed by the low 
I ( upper pane0, medium ( middle 
pane0 and high ( lower pane0 gain 
amplifiers with their flight times for 
the TEPC in helix mode. 
Other distinct features in the pulse height data were observed with increasing TOF 
and hence decreasing incident neutron energy. A reduction in the frequency of both 
small (high gain) and large (medium and low gains) pulse height events was evident. 
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This reflects a shift in the fast proton component towards higher values of lineal 
energy and smaller contributions from the heavy ion and alpha dose components as 
the neutron energy decreases. 
When all pulse height events are projected onto the time axis, the observed timing 
resolution of the counter is adversely affected by time slewing. However, when a 
narrow band or window of pulse heights is selected at various positions on the pulse 
height scale and the data bound by the window then projected onto the time axis, the 
inherent timing capabilities of the TEPC are revealed. Two such projections made 
from the low (upper panel) and high (lower panel) gain data are shown in Figure 
0 100 200 300 400 
Channel number (0.76ns per channel) 
Figure 6.11 Projections onto 
the time axis of thin slices of 
pulse height data detected by 
the TEPC in helix mode and 
registered in the low gain 
( upper pane0 and high gain 
( lower pane0 amplifiers. In 
this representation the abscissa 
scales are reversed. The 
measured resolutions ( F WHM) 
of the monoenergetic peaks are 
5. 2 and 5. 9 ns respectively. 
The respective FWHM of 5.2 ns and 5.9 ns are representative of what is found for the 
whole range of pulse heights. At smaller pulse heights there is an apparent 
deterioration in the shape of the TOF spectrum as illustrated in the lower panel 
where the projection was made just above the threshold of pulse height measurement. 
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The two cuts in Figure 6.11 exhibit structure comparable to that obtained with the 
NE213 detector and suggest that events can indeed be identified with a TEPC on a 
TOF basis. 
Time slewing correction 
Off-line compensation for time slewing was considered justified and the data for each 
gain setting separately adjusted according to the following procedure. At each gain 
the correct time position was ascertained by examining the time of arrival for the 
larger pulse height events. This provided different reference points in time depending 
upon the amplification stage. A smooth curve was then drawn by eye through loci 
given by the data points of first arrival for each pulse height bin and the time 
difference between the reference and slewed events determined. The data were then 
replayed, event-by-event, and each time slewed event corrected using the 
corresponding time increment. The spectra in Figure 6.12 show projections onto the 
time axis after correcting all the data points from the individual amplifiers for time 
slewing. Monoenergetic peak widths of between 7 and 8 time channels were obtained 
with a time calibration of 0. 76 ns per channel giving a YWHM of less than 6 ns for 
each gain. Events associated with the nominal energy were now unambiguously 
identified and could be selected by setting a linear gate on these time spectra. The 
small peak in the panel of the high gain amplifier spectrum corresponds to the 
expected TOF for photons originating at the target. 
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Projections onto the time axis of all the pulse height data from the 
TEPC for the low ( upper pane0 medium ( middle pane0 and high 
( lower panel) gain amplifier after compensating for time slewing. 
The measured resolutions (FWHM) of the monoenergetic peaks are 
all less than 6 ns. 
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Complementary CPC study 
A complementary study under similar experimental conditions was performed with 
the CPC and comparable results obtained. The electrical characteristics of the CPC 
are nearly identical to the TEPC and the same voltage combination of 480 V (anode) 
and -100 V (helix) was applied. Using this counter electronic noise was slightly 
reduced and the discriminator on the ARC timer lowered accordingly (to "'0.4 mV). 
Figure 6.13 shows the composite TOF spectrum for the entire range of pulse heights 
and the two-dimensional density plots of TO F relative to pulse height for the 
individual amplifiers. Time slewing was again apparent on the well separated photon 
and neutron event clusters, and off-line correction was applied to give the TOF 
spectra for each gain stage depicted in Figure 6.14. The FWHM ( <6 ns) of the 
monoenergetic peaks compare well with their TEPC counterparts but the low energy 
tails are less pronounced and do not extend to longer flight times. The lack of 
response of the CPC to lower energy neutrons (E 11 <l0 MeV) is ascribed to the 
various energy thresholds which need to be exceeded before the nuclear reactions can 
proceed (Del Guerra, 1976). 
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Figure 6.13 Composite TOF 
spectrum for the entire ran~e of 
pulse heights ( right hand-side) and 
two-dimensional density plots ( left 
hand-side) correlating pulse height 
events processed by the low ( upper 
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high ( lower pane0 gain amplifiers 
with their flight times for the CPC 
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Projections onto the reversed time axis of all pulse height data from 
the CPC for the low ( upper pane0 medium ( middle pane0 and high 
( lower panel) gain amplifiers after compensating for time slewing. 
The measured resolutions ( FWHM) of the mono energetics peaks are 
all less than 6 ns. 
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A distinct change in shape of the low energy tail was also observed bet ween the low 
and high gain time spectra of the CPC. This is because the high gain amplifier 
primarily registers events associated with the fast proton component of the microdose 
distribution that result from neutron interactions in the carbon wall of the counter. 
The principal t2C(n,p)12B reaction requires the least energy (Q-value -12.59 MeV) of 
all proton releasing reactions ( Ajzenberg-Selove, 1985) and the diminished tail of the 
high gain TOF spectrum is attributed to the high energy threshold (13.63 MeV in the 
centre of mass frame) for proton events in the counter. 
Discussion 
In a high energy neutron field, spectrometry usrng TOF' reqmres a detector which 
generates a fast signal that ideally varies little in shape and amplitude. The signals 
from commercial 1/2-inch diameter Rossi counters exhibit none of these traits as 
they usually produce slow pulses of variable shape spanning a wide dynamic range. 
The inferior timing characteristics observed with these counters are due to both 
intrinsic and extrinsic effects. Previous attempts to attain a practicable time 
response have concentrated on reducing the size of the sensitive volume without 
necessarily considering how best to derive the time pick-off and how related timing 
artefacts could impair the performance. (Randers-Pehrson et al, 1983; Schrewe et 
al., 1989). Whilst smaller detectors promise faster timing the problems of pulse shape 
and amplitude variations will still be apparent as these are related to the nature of 
the single event distributions in lineal energy. 
The purportedly improved timing responses of low pressure proportional counters 
need to be viewed with some circumspection because of uncertainties associated with 
the measured microdose distributions. Randers-Pehrson et al. (1983) presented 
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time-correlated single event spectra which did not correspond well with conventional 
measurements and could not be satisfactorily calibrated. Similarly the description 
and subsequent use of a Rossi counter in helix mode (Schrewe et al., 1989; 
Schuhmacher et al., 1992) devote little attention to the actual microdose distributions 
obtained (in helix mode) and none are shown explicitly, nor are any TOF spectra 
given for high energy neutrons. 
The present work however, has conclusively shown that major improvements in the 
timing performance of commercial microdosimeters can be achieved whilst still 
preserving adequate pulse height resolution. A different voltage combination from 
that originally described for helix mode (Schrewe et al., 1989) was necessary to realize 
sufficient gas gain and pulse height resolution over the full range of lineal energies 
encountered in 66 MeV proton generated neutron fields. The optimised voltage 
settings allow reliable dosimetric data to be obtained from single event spectra 
measured in helix mode which are presented and shown to be equivalent to their 
counterparts measured in normal mode. 
The smaller size of the sensitive volume in conjunction with the new cylindrical 
geometry prohibits those events originating at distant ionization sites from being 
registered and provides an inherently faster time response for the detector. This 
allows the use of an appropriate timing discriminator such as an ARC timer to 
provide genuine TOF information. This time pick--off device reduces timing 
uncertainties due to variations in pulse rise times and minimizes amplitude walk 
utilizing the technique of constant fraction timing. Time triggers derived by leading 
edge methods (Schrewe et al., 1988a) are not suited to the large dynamic range of 
pulse heights common in microdosimetry and cannot accommodate a change in pulse 
rise-times without introducing an additional uncertainty in the measurement (Knoll, 
1979). 
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A proper combination of detector volume, timing discriminator and multi-parameter 
data acquisition are essential for true time-resolved microdosimetry. 
Two-dimensional data displays of TOF relative to pulse height show the photon and 
neutron events generated at the target clearly separated in time for the most 
stringent TOF example envisaged, namely that of a 63 MeV generated neutron field. 
Previous studies in high energy neutron fields have failed to show photon and neutron 
related events resolved in time, even though the measurements were performed in 
beams of lower neutron energy where the difference in flight times between the two 
components was greater per unit distance travelled than those used in this study. In 
all instances amplitude walk cannot be eliminated completely but can be easily 
identified, as shown by the presented data where off-line compensation for time 
slewing is demonstrated for the first time. 
The true timing capabilities of the helix mode configuration once revealed, enabled 
distinct structure associated with the incident energy spectrum to be discerned at all 
measurable pulse heights. Neutrons of nominal energy 62.6 MeV were identified in a 
peak of width 5.9 ns (FWHM). This compares favourably to the best timing response 
of 14 ns reported with a miniature TEPC in a 25 MeV neutron field (Randers-
Pehrson et al., 1983). Only with a comprehensive appreciation of the helix mode of 
operation and related pulse processing can single event spectra be reliably correlated 
in time. Direct assessment of the kerma associated with a high energy neutron of 
specified energy is now realizable for the first time and measurements performed at 
three different energies spanning the 20--65 MeV energy range are described in the 
following chapter. 
CHAPTER 7 
KERMA ASSOCIATED WITH HIGH ENERGY NEUTRONS 
Introduction 
In the energy range 20-{iS MeV uncertainties still exist in the experimental values 
obtained for neutron kerma factors in the materials and elements of dosimetric 
interest (White et al., 1992). Two experimental assessments using independent 
methods have been made but were unable to provide a direct measurement of the 
total kerma for selected monoenergetic neutrons. Adjustments to the data of between 
40-50% were required to accommodate experimental inadequacies resulting from 
either an incomplete data set (Romero et al., 1985) or contamination of the kerma 
measurement by extraneous contributions from low energy neutrons (Schuhmacher et 
al., 1992; Schrewe et al., 1992a). 
The present study utilizing a TEPC and CPC operating in helix mode shows how the 
total kerma associated with a high energy monoenergetic neutron can be measured 
directly without the application of large correction factors. Optimization of the 
timing response of the detectors enables genuine energy spectrometry of the kerma 
related events on the basis of TOF. This overcomes the difficulties previously 
experienced in quasi-monoenergetic neutron distributions where kerma events due to 
neutrons other than those of the nominal energy are registered and extends the useful 
range of kerma assessments at specific neutron energies with low pressure 
proportional counters. The present data are the first reported microdose distributions 
measured for truly monoenergetic neutrons in the energy range 20-{iS i\IeV. 
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The evaluation of kerma from a measurement with an ionization chamber or 
proportional counter requires knowledge of the energy dependent parameter r , the 
m,g 
gas-to-wall dose conversion factor. A value of unity is usually appropriate for a 
homogeneous detector system where the gas filling has the same elemental 
composition as the wall material of the counter. Whilst a TEPC with TE gas is 
considered homogeneous, values of r for the heterogeneous combination of a 
m,g 
graphite walled proportional counter filled with TE gas need to be determined. 
Comparison of the measured monoenergetic microdose spectra obtained under 
identical irradiation conditions with the TEPC/CPC pair of detectors provides such 
an evaluation. Similarly the kerma ratio of carbon to A-150 was assessed and 
compared with other reported values to demonstrate the viability of this method for 
future neutron kerma factor evaluations. 
Materials and Methods 
To augment the measurements already described at 62.6 ±0.9 MeV (Chapter 6) 
additional irradiations at two different energies were carried out at the neutron TOF 
facility. Collimated neutron fields with monoenergetic peak energies of 25.5 
±1.8 MeV and 42.0 ±1.2 MeV were generated by bombarding the 1.1 mm thick Be 
target with protons of incident energy 29.1 ±0.1 MeV and 45.0 ±0.2 MeV respectively. 
Heat dissipation in the solid target restricted the maximum proton beam intensities 
in each instance to 2.5 µA (25.5 MeV), 3.5 µA (45.0 MeV) and 5µA (62.6 MeV). 
Dose assessments were determined with the TEPC and CPC under the same 
experimental conditions described in Chapter 6. 
The build-up cap wall thicknesses used in the 25.5 and 42.0 MeV beams were 
respectively 6 and 13 mm for the TEPC, and 1.5 and 5.5 mm for the CPC. These 
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cap thicknesses ensured secondary charged particle equilibrium for each irradiation. 
Single event spectra were measured with each counter operated in the two different 
modes. Conventional single parameter pulse height data were obtained for the 
different energies with the counter wall maintained at ground potential and voltages 
of 590V and 118V applied to the anode and helix. Thereafter measurements were 
performed with the counters operating in helix mode by changing the voltage settings 
to 480V (anode) and -lOOV (helix). TOF information was recorded only in helix 
mode using multi-parameter data acquisition on an event-by-€vent basis. This 
permitted replay of the data to correct for time slewing caused by the ARC timer and 
allowed the imposition of software gates as desired. 
The measured microdose distributions were calibrated by identifying the cut--Dff 
edges associated with the proton and alpha components. Spectra were adjusted until 
the most prominent edge was in the correct position on the lineal energy scale 
calculated from the maximum possible energy loss and mean chord length values 
(Table 6.5). The photon fraction of the total measured kerma was evaluated from the 
normal mode spectra and subsequently subtracted to give the neutron only kerma for 
each measurement. In normal mode the duration of a run was approximately 1 hour 
whereas time correlated helix mode measurements required continuous run times of 
between 11 and 20 hours. Temperature control of the experimental vault ensured a 
constant temperature (22 ±2° C) throughout. Gas gain stability was monitored using 
the internal alpha source by operating the counters in normal mode before and after 
each helix run. 
117 
Results 
Data extrapolation (helix mode) 
In helix mode the gas gam was sufficient to measure event sizes as small as 
approximately 0.5 keV (see Figure 6.6). The time--correlated measurements however, 
were subject to a higher pulse height threshold imposed by the discriminator setting 
on the ARC timer which was adjusted to eliminate electronic noise. This threshold 
was highest for the 62.6 MeV run with the TEPC where the smallest event size 
recorded was approximately 3 keV. To compensate for the loss of pulse height 
information, spectra acquired in multi-parameter mode were extrapolated to lower 
event sizes by fitting pulse height data measured under similar irradiation conditions 
in helix mode but using the conventional single parameter acquisition system. Pulse 
height data measured by the high gain amplifier with the TEPC in the 62.6 MeV 
quasi-monoenergetic neutron field are ill ustated in Figure 7 .1. The solid curve shows 
a projection onto the pulse height axis of all registered events in the TOF spectrum 
recorded in multi-parameter mode. The spectrum extending to smaller pulse heights 
(broken curve) was obtained from an independent single parameter measurement. 
Depending upon experimental conditions the dose accommodated by the 
extrapolation procedure varied between 0% (CPC at 25.5 MeV) and 26% (TEPC at 
62.6 MeV) of the total evaluated. In the most extreme instance matching of the 
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Figure 7 .1 Pulse height information 
registered by the high gain amplifier with 
the TEPC in the 62. 6 Me V quasi-
monoenergetic neutron field using the 
multi-parameter(--) and conventional 
( · · · ) data acquisition systems. The 
conventionally acquired data is displaced 
by a decade for cla1ity and was used to 
extrapolate the multi-parameter data 
acquired in helix mode. 
118 
single parameter and time-----<:orrelated spectra was estimated to introduce an overall 
uncertainty of less than 2.6% to the total dose determinations. 
TEPC microdose distributions 
Microdose distributions for the three quasi-monoenergetic neutron fields measured 
with the TEPC operating in both normal (upper panel) and helix (lower panel) 
modes are shown in Figure 7.2. The helix mode spectra were obtained from 
projections onto the pulse height axis of all registered events in the TOF spectrum 
and have been extrapolated to lower event sizes as described above. 
The calibrated spectra have been normalised to unit dose and exhibit the same 
changes with energy, irrespective of the operating mode. The distributions are 
dominated by large fast proton components that migrate to lower lineal energies as 
the incident neutron energy increases. At the lower beam energies where a greater 
proportion of the incident proton energy is lost in the target, the microdose spectra 
have more slow protons per unit dose. Above the proton edge the alpha and heavy 
ion contributions appear to differ little in shape. These findings are consistent with 
those previously reported where thicker Be targets were bombarded with protons of 
incident energies 35, 45 and 65 MeV (Heintz et al., 1977; Amols et al., 1977). 
Fractional photon dose contributions of 2.9 ±0.3% were assessed for the 25.5 MeV and 
42.0 MeV beams with a slightly smaller value of 2.2 ±0.2% for the 62.6 MeV beam. 
CPC microdose distributions 
Dose normalized rnicrodose distributions measured with the CPC in the three 
different quasi-monoenergetic neutron fields are shown in Figure 7.3. A good 
correspondence between the normal (upper panel) and helix (lower panel) mode 
spectra is apparent with more dramatic changes noted in the character of the 
.3 
.2 
. 1 
,,---..... 
>, 
'-../ 
.0 
-a 
>, 
.3 
.2 
. 1 
.0 
Figure 7.2 
119 
10° 10 1 10 2 
y (keV µm- 1) 
Normalised microdose distributions measured with the TEPC in 
normal ( upper pane0 and helix ( lower pane0 modes for three different 
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monoenergetic neutron fields of nominal peak energies 25. 5 
( · · · ), 42. 0 (-) and 62. 6 ( - - - ) Me V. 
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distributions with varying energy than those observed for the TEPC. At all energies 
the alpha particle and heavy ion dose components can be clearly identified. The most 
striking feature is the presence of a marked contribution resulting from (n,p) 
reactions in the carbon wall at higher neutron energies. The fast proton peak is seen 
to increase in magnitude and migrates to lower values of lineal energy as the incident 
neutron energy increases. These spectra concur with those measured in similar 
neutron fields (Menzel et al., 1988). 
Measured absorbed dose for high energy neutrons 
Off-line compensation for the observed time slewing was applied to the 
time--<:orrelated data which were replayed event-by-event with software gates set to 
embrace the principal energy for each TOF spectrum. Pulse height data with a TOF 
falling within the window were selected and modified dose distributions obtained. 
Figure 7.4 (upper panel) shows the full ungated TOF spectrum for the 
quasi-monoenergetic beam using the CPC in the 25.5 MeV beam with the gated 
monoenergetic events identified by the hatched area. In this representation the 
abscissa scale is reversed. The corresponding dose distributions are also depicted 
(lower panel) and are normalised to provide the neutron kerma per monitor count for 
the gated monoenergetic neutrons relative to the ungated quasi-monoenergetics. 
Similarly Figure 7.5 shows spectra measured with the TEPC in the 42.0 MeV beam 
and Figure 7.6 those obtained in the 62.6 MeV beam with the CPC. 
The TOF spectra are all consistent with those measured using the NE213 liquid 
scintillator and reflect the change in character of the generated quasi-monoenergetic 
neutron energy distributions with the principal peak becoming narrower as the 
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Figure 7.4 TOF spectrum 
corrected for time slewing 
( upper pane0 and microdose 
distributions normalised to 
500 relative neutron fluence 
10~ 
obtained in helix mode ( lower 
pane0 with the CPC in the 
25. 5 Me V quasi-mono energe-
tic neutron field. The hatched 
areas delineate selected events 
of the nominal neutron energy. 
incident proton energy mcreases. Differences between the ungated and gated 
micro dose distributions in both area (dose) and shape also become more apparent 
with increasing neutron energy. The gated monoenergetic 62.6 MeV microdose 
distribution measured with the CPC (Figure 7.6) exhibits a prominent fast proton 
contribution such that the characteristic shape of the spectrum more closely 
resembles that which might be expected of a TEPC rather than a CPC. This again 
illustrates the importance of the (n,p) reaction on carbon for dose assessments at 
higher neutron energies. 
Calibration of each of the quasi-monoenergetic dose distributions was performed 
prior to the setting of TOF gates. Comparison of the measured doses expressed per 
monitor count for the normal and helix mode distributions (Figs 7.2 and 7.3) showed 
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Figure 7.5 TOF spectrum 
corrected for time slewing 
500 ( upper pane0 and microdose 
distributions normalised to 
relative neutron fluence 
obtained in helix mode ( lower 
pane0 with the TEPC in the 
4 2. 0 Me V quasi-monoenergetic 
neutron field. The hatched 
areas delineate selected events 
of the nominal neutron energy. 
good agreement and corresponded within 2% for each energy. Table 7.1 lists the 
neutron dose per monitor count obtained in helix mode for the ungated 
quasi-monoenergetic and gated monoenergetic distributions. The lower energy limit 
( threshold) for each gate setting spanning the principal neutron peak is also included 
together with the fractional neutron dose contribution from the peak relative to that 
for the entire quasi-monoenergetic distribution. This fractional proportion of the 
dose is always greater for the CPC than the TEPC as the carbon counter is 
insensitive to the lower energy neutrons in the quasi-monoenergetic distributions. 
The results also indicate a smaller fractional dose contained within the principal 
energy peak of the quasi-monoenergetic distributions as the bombarding proton 
energy is increased. This is consistent with the recent findings of Schuhmacher et al., 
(1992) and Schrewe et al. (1992a), performed in quasi-monoenergetic neutron beams 
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Figure 7.6 TOF spectrum 
corrected for time slewing 
500 ( upper panel) and microdose 
distributions normalised to 
relative neutron fluence 
obtained in helix mode ( lower 
pane0 with the CFC in the 
62. 6 Me V quasi-mono ener-
getic neutron field. The 
hatched areas delineate selected 
events of the nominal neutron 
energy. 
Neutron doses measured in the sensitive volume and expressed per 
monitor count for the TEFC and CFC under indentical irradiation 
conditions in three quasi-monoenergetic neutron fields. 
TEPC 
Gate threshold D D D /D . quasi mono mono quasi 
(MeV) (cGyc-1) (cGyC-1) (%) 
16 128.19 72.72 57 
33 129. 71 58.68 45 
50 141.62 60.95 43 
CPC 
Gate threshold D D D /D . quasi mono mono quasi 
(MeV) (cGyC-1) (cGyc-1) (%) 
16 56.26 43.26 77 
33 67.01 40.32 60 
50 93.12 45.31 49 
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similarly generated by bombarding a 2 mm thick Be target with protons of various 
incident energies ranging from 31.9 to 71.2 MeV. 
Gas-to-wall dose conversion factor, r 
m,g 
Gas-to-wall dose conversion factors for a TE gas filled CPC have previously been 
determined using the ionization yield spectra measured with both a TEPC and CPC 
under identical irradiation conditions (Menzel et al., 1988). The method assumes 
that the dose contribution above the proton edge in the TEPC distribution results 
only from neutron interactions with carbon atoms in the A-150 plastic and that the 
r for the TEPC with TE gas filling is unity. 
m,g 
Spectra were normalised to relative neutron fluence using the beam monitor counts 
and the CPC measurements scaled down to the percentage of elemental carbon in 
A-150 plastic (0.776). The ratio (TEPC/CPC) of the dose integrals above the 
proton edge for each pair of measurements then gave the r value for the CPC in 
m,g 
that particular neutron field. Values were determined at each of the three nominal 
energies employing identically gated paired microdose spectra. To aid comparison 
with published data, values were also obtained using ungated helix and normal mode 
quasi-monoenergetic spectra. These are presented in Table 7.2 where an overall 
uncertainty of ±6% is assumed (Pihet and Menzel, 1989). Utilizing data for 
quasi-monoenergetic neutron beams over the energy range 25.5 to 62.6 MeV yields a 
constant r for the CPC with the isobutane based TE gas filling and is in 
m,g 
agreement with those previously reported using propane based TE gas (Menzel et al., 
1988). 
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Table 7.2 Gas-to-wall dose conversion factors for the graphite counter with a TE 
gas filling. Values determined by Menzel et al., {1988) at similar 
energies have been included. 
E r En r n m,g m,g 
(MeV) Normal Helix Monoenergetic (MeV) (Menzel et al.) 
25.5 0.84 0.83 0.80 27.8 0.85 
42.0 0.85 0.83 0.80 39.7 0.83 
62.6 0.84 0.83 0.88 60.3 0.84 
Values determined with gated monoenergetic spectra, whilst consistent with these 
findings up to 42 MeV, appear to increase at higher neutron energies. In this energy 
range calculations of r using stopping power data in conjunction with measured 
m,g 
microdose spectra also indicate this trend (Pihet et al., 1992b). The values from the 
monoenergetic data are consistent with those of 0. 794 ±0.036 at 27 MeV and 0.802 
±0.045 at 39 MeV recently deduced by Schuhmacher et al. (1992). 
Ratio of carbon to A-150 kerma 
The kerma per monitor count was determined for each gated monoenergetic spectrum 
by multiplying the measured dose by the appropriate r value given in Table 7.2. 
m,g 
An r value of unity was assumed for the TEPC for each energy (Pihet et al., m,g 
1992b ). The kerma per monitor count measured with the CPC relative to that of the 
TEPC was then calculated for each of the three energies. No corrections for neutron 
scattering and attenuation in the walls of the build-up caps were applied. Overall 
uncertainties associated with the results are considerably reduced when examining 
kerma ratios, with the major source of error being calibration of the microdose 
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distribution. This uncertainty was conservatively estimated as 5.6% for each 
spectrum. 
The kerma ratios are plotted as a function of neutron energy in Figure 7. 7 together 
with other experimental values (Romero et al., 1985; Schuhmacher et al., 1992, 
Schrewe et al., 1992a) and three theoretical curves for En>20 MeV. Carbon, nitrogen 
and oxygen kerma factors calculated by Alsmiller and Barish (1977), Dimbylow 
(1982) and Brenner (1983) were used together with published hydrogen kerma factors 
(Fleming, 1974; Bassel and Herling, 1977) to obtain the theoretical curves. Romero 
et al. (1985) have quoted typical uncertainties of 2-3% for their results, but this only 
accounts for the fraction of kerma that was measured in the experiment. The 
uncertainties associated with their total kerma values are undoubtedly larger and the 
errors surrounding their corresponding kerma ratios are probably more comparable 
with those reported in this study . As the true uncertainties for the Romero data 
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remain speculative, error bars for their plotted values have been omitted from the 
figure. 
The kerma ratios derived from the time gated microdose spectra in conjunction with 
the determined r values concur with other published data using different 
m,g 
techniques. The results exhibit the same general trend as predicted by calculations 
and most closely approximate the curve of Alsrniller and Barish. 
Discussion 
Whilst neutron kerma factors can be predicted theoretically, large uncertanties exist 
in the nuclear model calculations because of incomplete data sets used as input for 
the energy range above 20 MeV. Experimental determination of kerma factors has 
been undertaken but the methods employed have been far from ideal as the actual 
kerma assessments were either incomplete or suspect due to contamination by low 
energy neutrons. 
Romero et al. (1985) selecting monoenergetic neutron events measured only the 
partial kerma from secondaries with masses A ~ 4. The heavy ion contribution was 
estimated by applying sum rules relating the double differential cross sections, 
obtained from the inclusive measurements of the separate charge particle spectra, to 
the total non--€lastic cross sections. Depending upon the element and neutron 
energy, corrections of between 13 and 40% were necessary. These corrections also 
accommodated the energy threshold of the experiment ( 4 MeV) below which no cross 
section data were measured. 
Schuhmacher et al. (1992) were able to measure the total kerma for A-150 plastic 
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and carbon using proportional counters but were nevertheless obliged to make 
corrections of 30-50% because the assessments were contaminated by a large low 
energy neutron component. In their evaluation it was not possible to identify the 
kerma from either the contaminating neutrons or the neutrons of interest. To 
account for the ensuing kerma contamination corrections were principally derived 
using known kerma factor values in the 10-20 MeV region in combination with 
measurements of the spectral neutron fluence. The expressed uncertainty for the 
applied kerma factors was between 5.1 and 7.5% (Pihet et al., 1992b) but the spectral 
fluence obtained with the liquid scintillator NE213 was considerably influenced 
( ±30%) by the experimental threshold employed which did not extend to low neutron 
energies. The kerma for neutrons of energy less than 10 MeV was determined by 
TOF spectrometry with the TEPC and CPC operating in normal mode. The actual 
timing resolution obtained is not stated, nor are TOF spectra shown and the ability 
to unambiguously identify neutron events of a specific energy is considered 
questionable. At a distance of 9 m the times of arrival for neutrons with energies 39 
and 10 MeV are 104 ns and 182 ns respectively. The time difference of 78 ns between 
the two energies is comparable to the 77 ns time interval between the high energy 
neutrons and a photon emanating from the target. Schuhmacher et al., (1992) do not 
show photons separately resolved from the neutrons which, if indicative of the timing 
resolution that prevailed, suggests there is no justification for assuming that 10 MeV 
neutron events were distinguished from 39 MeV events on the basis of neutron TOF. 
In view of these potentially large sources of error the stated overall uncertainties for 
the assessed kerma per monitor count of between 4.3 and 7 .2% appear highly 
optimistic and the agreement with Romero et al. (1985) possibly fortuitous. 
Similar measurements were performed by Schrewe et al. ( 1992a) at neutron energies 
between 44.5 and 66.0 MeV. The reported value at 58.4 MeV is from the work of 
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Menzel et al. (1988) where no account of spectral neutron fluence was made. 
Moreover the cap material used in the measurement by Menzel et al., (1988) was not 
A-150 plastic but polyethylene, which can be expected to provide a markedly higher 
kerma response (see Build-up, Chapter 4). The correction for low energy 
contamination at 66.0 MeV is dependent upon the kerma factor derived at 58.4 MeV 
and needs therefore to be viewed with caution. This probably explains the large 
quoted uncertainty for the 66 MeV data point and emphasises the shortcomings in 
this approach at higher neutron energies. 
Verification of the reported kerma factors is essential if these values are to be 
accepted with the confidence required by clinical neutron dosimetry. The advantages 
of integral kerma measurements in kerma factor assessments with low pressure 
proportional counters manufactured from different wall materials was recognised 
(DeLuca et al., 1984; Menzel et al., 1984, Buhler et al., 1985) and has contributed to a 
revised set of carbon kerma factors below 20 MeV which differ significantly from the 
previously accepted values (Caswell et al., 1988). Whilst there are inherent 
uncertainties associated with the use of gas filled proportional counters such as 
knowledge of the W n/W c value for the counter gas and values for the gas-to-wall 
dose conversion factors r , the principal constraint on the method at higher energies m,g 
is the absence of pure monoenergetic neutron sources. 
Energy spectrometry of kerma related even ts on the basis of TO F overcomes this 
difficulty and enables a direct assessment of r for the heterogeneous combination 
m,g 
of graphite counter filled with isobutane based TE gas. Values of r are energy 
m,g 
dependent and essential for accurate kerma determinations. Utilizing 
quasi-monoenergetic neutron beams the present data yielded a constant r whereas 
m,g 
values obtained with gated monoenergetic spectra indicate an increase at higher 
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neutron energies. Calculations using various nuclear models predict an increase in 
the ratio of carbon to A-150 kerma factors for increasing neutron energy (Schrewe et 
al., 1992a) with differences becoming less between the total responses of the CPC and 
TEPC. This then implies that the CPC acts more "tissue equivalent like" at higher 
incident neutron energies and that r should approach unity. The gated 
m,g 
monoenergetic microdose distribution measured with the CPC at 62.6 MeV with its 
pronounced proton dose component appears consistent with this premise as the 
characteristic shape resembles what might be expected from a TEPC. An analysis of 
the overall uncertainties associated with r was not considered here, as the initial 
m,g 
aim was to illustrate the value of true monoenergetic microdose data. In particular 
an oversimplification may be the assumption that the dose contribution above the 
proton edge in the TEPC measured distributions results only from neutron 
interactions with carbon atoms. The A-150 plastic also contains 5.2% oxygen and 
3.5% nitrogen by weight and neutron interactions with these atoms can be expected 
to contribute to the measured response of the TEPC at higher energies. Calculations 
show the significance of the kerma factors for the respective elements (Behrooz and 
Watt, 1981) and recent measurements have illustrated the similarity in the ionization 
yield spectra measured for ox;x-gen and carbon (Schrewe et al., 1992b ). In gated high 
energy monoenergetic beams a more suitable approximation might be to incorporate 
the nitrogen and oxygen by summing the proportions of carbon, nitrogen and oxygen 
in A-150 plastic with their respective percentage weights multiplied by an assumed 
kerma factor for each element relative to that of carbon. Neutron interactions with 
carbon atoms in the TEPC spectra would then be responsible for the fraction of the 
measured dose above the proton edge given by 0. 776 divided by the weighted sum. If 
equal kerma factors for the three elements are chosen as an extreme example then the 
evaluated r values would be reduced by approximately 11 %. This would directly 
m,g 
affect the kerma ratios obtained in this study by placing them close to the prediction 
of Brenner. 
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Nevertheless the feasibility of time-resolved rnicrodosimetry usmg commercial 
Rossi-type proportional counters has been demonstrated. Direct measurement of 
kerma associated with high energy neutrons is possible with a single detector and 
rnicrodose spectra associated with truly monoenergetic neutrons can be used to derive 
carbon to A-150 plastic kerma ratios that concur with theoretical predictions and 
other experimental values. By eliminating those procedures and methods that are 
needed to account for events registered by the detector other than those of interest 
will help to improve the overall accuracy with which integral kerma measurements 
can be performed with low pressure proportional counters at selected neutron 
energies. 

CHAPTER 8 
SUMMARY 
Clinical dosimetry demands that the delivered absorbed dose to the target volume be 
specified with an accuracy of± 3.5% regardless of the radiation modality used. In the 
hope of enhancing the efficacy of fast neutron therapy this work investigates the two 
largest obstacles confronting this objective for a p(66)/Be(40) beam. Firstly the 
problem of heterogeneous beam quality was addressed using microdose distributions 
which revealed changes in beam potency that were considered clinically significant. 
In the second half of the study TOF techniques were successfully applied employing 
commercial Rossi counters to enable a direct assessment of the total kerma associated 
with neutrons of a specific energy in the interval 20-{35 MeV. 
A thorough microdosimetric investigation of the p( 66) /Be( 40) therapy beam was 
performed with a tissue equivalent proportional counter. The measured lineal energy 
spectra and derived averages were observed to change for different irradiation 
conditions pertinent to therapy. Using the parameter y* as an indicator of radiation 
quality, variations in the potency of the beam were quantified with spatial position 
and field size in a water phantom, and in the dose build-up region measured in-air. 
A 6% decrease in y* when movmg to greater depths in-phantom was attributed 
solely to changes in character of the neutron component and appears independent of 
field size. The slight increase in the photon dose fraction does not play a role in the 
observed changes. Conversely increasing field size leads to an overall enhancement of 
3% in beam effectiveness where an amelioration of the neutron component following 
scattering is tempered by the growing photon dose fraction. A similar interplay 
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between the high and low LET components was also evident in the penumbra! region 
when moving across the lateral plane of a collimated field. Studies in the build-up 
region demonstrated the value of identifying individual components that contribute 
to the total absorbed dose. Reduced doses in the build-up region are shown to result 
from a smaller proton dose relative to the high LET (y> 140 keV µm-1) component. 
Compared to a position at full build-up the beam is 24% more effective at a depth of 
1.3 mm. 
To accommodate these quality changes in the prescription of absorbed dose, the 
concept of effective dose was invoked and elementary expressions proposed to assess 
this quantity. The measured y*-values are employed to calculate a range of 
weighting factors which were normalised to unity at a selected reference position. 
Effective dose Deff was then derived in terms of the conventionally measured total 
dose Dt as a function of depth, field size and lateral position. Whilst the discrepancy 
between Deff and Dt was of little clinical consequence when moving across the lateral 
plane of the field and through the penumbra, changes with depth and field size 
appeared to merit further consideration. As illustration a conventional 4-field 
treatment plan to irradiate a symmetrically located 10 x 10 x 10 cm 3 tum our in the 
pelvic region was prepared and compared to that obtained when the total dose input 
data was replaced by effective dose. A 4% reduction in the dose to the tumour 
volume was apparent for the effective dose calculation. In the clinical situation where 
fractionated doses are delivered this discrepancy could be accentuated. If the noted 
variations in beam quality are ignored they will undermine attempts at achieving the 
desired clinical accuracy in the physical specification of absorbed dose. 
To facilitate a direct assessment of the total kerma associated with high energy 
neutrons investigations were performed in pulsed beams of quasi-monoenergetic 
135 
neutrons. The timing characteristics of commercial proportional counters routinely 
used in microdosimetry were studied to allow energy spectrometry of the recorded 
events utilizing the technique of TOF. A proper combination of detector volume, 
timing discriminator and multi-parameter data acquisition proved essential. After 
accounting for amplitude walk significant improvements were achieved whilst 
maintaining an adequate pulse height resolution over the extended range of lineal 
energies encountered in a high energy neutron field. Operating in helix mode the 
tissue equivalent and carbon proportional counters exhibit inherent timing responses 
(FWHM<6 ns) that compare favourably with that of an NE213 liquid scintillator 
(FWHM=3.8 ns). Distinct structure associated with the incident energy spectrum is 
discernible and enabled the unambiguous selection of energy deposition events 
resulting from neutrons of the nominal energy. 
Time-correlated microdose spectra were measured in three different quasi-
monoenergetic neutron fields with principal peak energies of 25.5, 42.0 and 62.6 MeV. 
The time gated spectra are the first reported microdose distributions for truly 
monoenergetic neutrons in this energy range. The gas-to-wall dose conversion factor 
for the TE gas filled carbon counter was evaluated from the data so obtained and 
appeared to increased from 0.8 to 0.88 in the energy range investigated. 
Subsequently the kerma ratio of carbon to A-150 plastic was determined and the 
results found to concur with other published data using different techniques. 

REFERENCES 
Ajzenberg-Selove F. (1984). Energy levels of light nuclei A = 5-10. Nuclear Physics 
A413, 1-168. 
Ajzenberg-Selove F. (1985). Energy levels of light nuclei A = 11-12. Nuclear 
Physics A433, 1-158. 
Alsmiller R.G. and Barish J. (1977). Neutron kerma factors for H, C, N, 0 and 
tissue in the energy range 20-70 MeV. Health Phys. 33, 98-100. 
Amols H.I., Dicello J.F., Awschalom M., Coulson L., Johnsen S.W. and Theus R.B. 
(1977). Physical characterization of neutron beams produced by protons and 
deuterons of various energies bombarding beryllium and lithium targets of several 
thicknesses. Med. Phys. 4 (6), 486-493. 
Andersen H.H. and Ziegler J.F. (1977). Hydrogen stopping powers and ranges in all 
elements. In: The stopping and ranges of ions in matter Vol. 3 (J.F.Ziegler, Ed.) 
Pergamon Press, New York, U.S.A. 
Barendsen G. W., Walter H.M.D., Fowler J.F. and Bewley D.K. (1963). Effects of 
different ionizing radiation on human cells in tissue culture. III. Experiments with 
cyclotron accelerated alpha-particles and deuterons. Radiat. Res. 18, 106-119. 
Bassel R.H. and Herling G.H. (1977). Energy transfer to hydrogen by neutrons from 
30 to 100 MeV. Radiat. Res. 69, 210-212. 
137 
Beach J.L. and Milavickas L.R. (1982). Microdosimetric measurements of radiation 
quality variation in homogeneous phantoms irradiated by fast neutron beams. Med. 
Phys. 9, 52-59. 
Beauduin M., Gueulette J., De Coster B.M., Gregoire V., Octave-Prignot M., 
Vynckier S. and Wambersie A. (1989). Radiobiological intercomparisons of fast 
neutron beams used in therapy. Proceedings of the EORTC-Heavy Particles Therapy 
Group Meeting, Munich, October 1987. Strahlenther. Onkol. 165, 263-267. 
Behrooz M.A. and Watt D.E. (1981). Kcrma factors for neutrons of 14 MeV to 60 
MeV in elemental H, C, N and 0. Radiat. Prot. Dosim. 1 (4), 291--297. 
Bewley D.K., McNally NJ and Page B.C. (1974). Effect of the secondary 
charged-particle spectrum on cellular response for fast neutrons. Radiat. Res. 58, 
111-121. 
Bewley D.K. (1989). The physics and radiobiology of fast neutron beams. Adam 
Hilger, Bristol, England. 
Binns P.J. and Hough J.H. (1987). Spectral energy measurements in a fast neutron 
therapy field. Nucl. Inst. Meth. A255, 330-333. 
Binns P.J. and Hough J.H. (1988). Lineal energy measurements in two fast neutron 
beams: d(16)+Be and p(66)+Be. Radiat. Proc. Dosim. 23, 385-388. 
Binns P.J. and Hough J.H. (1992). Consideration of radiation quality in treatment 
planning with p(66)/Be(40) neutrons. Int. J. Radiat. Oncol. Biol. Phys. 24, 975-981. 
138 
Binns P.J., Hough J.H. and Simpson B.R.S. (1992). Time-resolved microdosimetry 
in a quasi-monoenergetic neutron beam. Radiat. Prot. Dosim. 44, 67-71. 
Birkhoff, R.D., Turner J.E., Anderson V.E., Feola J.M. and Hamm R.N. (1970). The 
determination of LET spectra from energy-proportional pulse-height measurements. 
I. Track-length distributions in cavities. Health Phys. 18, 1-14. 
Bohm L., Gueulette J., Jones D.T.L., Beauduin M., Vynckier S., De Roubaix S., 
Yudelev M., Slabbert J.P. and Wambersie A. (1990). Radiobiological 
intercomparison of two clinical neutron beams usmg the regeneration of mouse 
intestinal crypts. Strahlenther. Onkol. 166, 242-245. 
Botha A.H., Conradie J.L., Roels L.M.M., Fourie D.T., Kritzinger J.J., Reitmann D., 
Cronje P.M., Celliers P.J., Fenemore RE., Carstens J.W., Kriel J.E., Nel W.A.G., 
Burger S.J., Van Rooyen D.M., Weehuizen H.F., Rohwer P., Cornell J.C., Jungwirth 
H.N. and Molteno P.G. (1991). Operation and development of the NAC accelerator 
facilities. In: Proceedings of the Twelfth International Conference on Cyclotrons and 
their Applications (B. Martin and K Ziegler, Eds.) Springer, Berlin, pp 80-83. 
Booz J. and Fidorra J. (1981). Microdosimetric investigations on collimated fast 
neutron beams for radiation therapy: II. The problem of radiation quality and RBE. 
Phys. Med. Biol. 26 (1), 43-45. 
Brenner D.J. (1983). Neutron kerma values above 15 MeV calculated with a nuclear 
model applicable to light nuclei. Phys. Med. Biol. 29 (4), 437-441. 
139 
Broerse J.J., Barendsen G.W. and Kersen G.R. (1968). Survival of cultured human 
cells after irradiation with fast neutrons of different energies in hypoxic and 
oxygenated conditions. Int. J. Radiat. Biol. 13, 559-572. 
Broerse J.J., Mijnheer B.J. and Williams J.R. (1981). European protocol for neutron 
dosimetry for external beam therapy. Brit. J. Radial. 54, 882-898. 
Budach V. (1991). The role of fast neutrons in radio-oncology - A critical appraisal. 
Strahlenther. Onkol. 167, 677---692. 
Buhler G., Menzel ll.G., Schuhmacher H., Dietze G. and Guldbakke S. (1986). 
Neutron kerma factors for magnesium and aluminium measured with low pressure 
proportional counters. Phys. Med. Biol. 31 (6), 601---611. 
Burger G., Maier. E and Morhart A (1978). Radiation quality and its relevance in 
neutron radiotherapy. In: Proceedings of the Sixth Symposium on Microdosimetry 
J. Booz and H.G. Ebert Eds.) CEC, Brussels, pp 451-468. 
Caswell R.S., Coyne J.J. and Randolph M.L. (1980). Kerma factors for neutron 
energies below 30 MeV. Radiat. Res. 83, 217-54. 
Caswell R.S., Coyne J.J., Gerstenberg H.M. and Axton E.J. (1988). Basic data 
necessary for neutron dosimetry. Radiat. Prot. Dosim. 23, 11-17. 
Catterall M. (1974a). The treatment of advanced cancer by Fast Neutrons from the 
Medical Research Council's Cyclotron at Hammersmith Hospital, London. Europ. J. 
Cancer 10, 343-34 7. 
140 
Catterall M. (1974b). A report on three years' fast neutron therapy from the Medical 
Research Council's Cyclotron at Hammersmith Hospital, London. Cancer 34, 91-95. 
Chase R.L., (1968). Pulse timing system for use with gamma rays m Ge(Li) 
detectors. Rev. Sci. Instrum. 39, 1318-1326. 
Cornell J.C., Lloyd G.C.W. and Fourie D.T. (1991). A neutron beam facility at 
NAC. In: Proceedings of the Twelfth International Conference on Cyclotrons and 
their Applications (B. Martin and K Ziegler, Eds.) Springer, Berlin, pp 594-597. 
DeLuca P.M. Jr., Barschall R.H., Haight R.C. and McDonald J.C. (1984). Kerma 
factor of carbon for 14.1 MeV neutrons. Rad. Res. 100, 78-86. 
DeLuca P.M. Jr., Barschall R.H., Burhoe M. and Haight R.C. (1986). Carbon kerma 
factor for 18- and 20-MeV Neutrons. Nucl. Sci. Eng. 94(2), 192-198. 
Del Guerra A. (1976). A compilation of n-p and n-C cross sections and their use in 
a Monte Carlo program to calculate the neutron detection efficiency in a plastic 
scintillator in the energy range 1-300 MeV. Nucl Inst. Meth. 135, 337-352. 
Dicello J.F. (1983). The contribution of secondary electrons to radiation fields 
produced by pion beams. In: Proceedings of the Eighth Symposium on 
Microdosimetry (J Boaz and HG Ebert, Eds.) CEC, Brussels, pp 223-230. 
Dimbylow P.J. (1982). Neutron cross-section and kerma value calculations for C, N, 
0, Mg, Al, P, S, Ar and Ca from 20 to 50 MeV. Phys. Med. Biol. 27 (8), 989-1001. 
141 
Duncan W., Arnot S.J., Batterman J.J., Orr J.A., Schmitt G. and Kerr G.R. (1984). 
Fast neutrons in the treatment of head and neck cancers: The results of a 
multi-centre randomly controlled trial. Radiother. Oncol. 2, 293-:rno. 
Duncan W., Arnott S.J., MacDougall R.H., Quilty P.M., Rodger A., Kerr G.E. and 
Williams J.R. (1985). A report of a randomized trial of d(15)+Be neutron compared 
with megavoltage X-ray therapy of bladder cancer. Int. J. Radiat. Oneal. Biol. 
Phys. 11, 2043-2049. 
Du Toit Z.B., Celliers P.J., Roels L.M.M., Conard, E.P., Kritzinger J.J. and Burger 
S.J. (1987). Operating experience with the light-ion injector of the NAC. In: 
Proceedings of the Eleventh International Conference on Cyclotrons and their 
Applications (M. Sekiguchi, Y. Yano and K. Hatanaka Eds.) Ionics, Tokyo, pp 
109-112. 
Fidorra J., Poli A. and Booz J. (1981). Experimental microdosimetric spectra and 
parameters of collimated fast neutron beams in a water phantom for different field 
sizes. In: Proceedings of the Seventh Symposium on Microdosimetry (J Booz, H G 
Ebert and H D Hartfiel, Eds.) CEC, Brussels, pp 1169-1179. 
Fidorra J. and Booz J. (1981). Microdosimetric investigations on collimated 
fast-neutron beams for radiation therapy: I. Measurements of microdosimetric 
spectra and particle dose fractions in a water phantom for fast neutrons from 14 MeV 
deuterons on beryllium. Phys. Med. Biol. 26 (1), 27-41. 
Field S.B. and Joiner M.C. (1990). Expression of dose m neutron therapy. 
Radiother. Oncol. 17, 73-80. 
142 
Fleming R.F. (1974). Energy transfer to hydrogen by neutrons up to 30 MeV. 
Radiat. Res. 60, 34 7-349. 
Goodhead D.T. (1982). An assessment of the role of microdosimetry in radiobiology. 
Radiat. Res. 9, 45-76. 
Goodhead D.T., Charlton D.E., Wilson W.E. and Paretzke H.G. (1985). Current 
biophysical approaches to the understanding of biological effects of radiation in terms 
of local energy deposition. In: Proceedings of the Fifth Symposium on Neutron 
Dosimetry (H. Schraube, G. Burger and J. Booz, Eds.) CEC, Brussels, 57---{)8. 
Goodman L.J. and Coyne J.J.(1980). W and neutron kerma for methane based n 
tissue equivalent gas. Radiat. Res. 82, 13-26. 
Hall E.J., Withers H.R., Geraci J.P., Meyn R.E., Rasey J., Todd P. and Sheline G.E. 
(1979). Radiobiological intercomparison of fast neutron beams used in therapy. 
Strahlenther. Onkol. 165, 263-267. 
Hall E.J., Zaider M., Bird R. and Astor M. (1982) Radiobiological studies with 
therapeutic neutron beams generated by p+--+Be or d +-+Be. Brit. J. Radiol. 55, 
640---{)44. 
Hall E.J., Astor. Mand Brenner D.J. (1992). Biological intercomparisons of neutron 
beams used for radiotherapy generated by p+--+ Be in hospital based cyclotrons. Brit. 
J. Radial. 65, 66-71. 
143 
Hartman G., Menzel H.G., Schuhmacher H., Hover K.H. and Granzow G. (1981). 
Radiobiological intercomparison of two fast neutron therapy units using CHO cell 
survival and its correlation to microdosimetry. In: Proceedings of the Seventh 
Symposium on Microdosimetry (J. Booz, H.G. Ebert and H.D. Hartfiel, Eds.) CEC, 
Brussels, pp 1181-1190. 
Heintz P.H., Johnsen S.W. and Peek N.F. (1977). Neutron energy spectra and 
dose-distribution spectra of cyclotron-produced neutron beams. Med. Phys. 4 (3), 
250-254. 
Hill C.K., Ten Haken R.K. and Awshalom M. (1991). The lethal effects of Fermilab 
fast neutrons vary with the depth of cells in a water phantom. Int. J. Radiat. Oneal. 
Biol. Phys. 20, 1341-1345. 
Hogeweg B., Zoetelief J. and Broerse J.J. (1978). RBE for cell survival at different 
positions in collimated neutron beams in relation to differences in lineal energy 
spectra. In: Proceedings of the Sixth Symposium on Microdosimetry (J. Booz and 
H.G. Ebert Eds.) CEC, Brussels, pp 507-516. 
Hornsey S., Myers R., Parnel C.J., Bonnett D.E., Blake S.W. and Bewley D.K. 
(1988). Changes in relative biological effectiveness with depth of the Clatterbridge 
neutron therapy beam. Brit. J. Radial. 61, 1058-1062. 
Hough J.H. and Binns P.J. (1990). Radiation quality in the penumbra! region of 
neutron therapy beams. In: Proceedings of the International Heavy Particle Therapy 
Workshop (PTCOG/EORTC/ECNEU), Villigen PSI, September 1989. Paul 
Scherrer Institute Report 69, pp. 105-107. 
144 
ICRU, Report 26 (1977). Neutron dosimetry for biology and medicine. International 
Commission on Radiation Units and Measurements, Bethesda, MD, USA. 
ICRU Report 29 ( 1978). Dose specification for reporting external beam therapy with 
photons and electrons. International Commission on Radiation Uni ts and 
Measurements, Bethesda, MD, USA. 
ICRU Report 33 ( 1980). Radiation quantities and units. International Commission 
on Radiation Units and Measurements, Bethesda, MD, USA. 
ICRU, Report 36 (1983). Microdosimetry. International Commission on Radiation 
Units and Measurements, Bethesda, MD, USA. 
ICRU, Report 45 (1989). Clinical neutron dosimetry. Part 1: Determination of 
absorbed dose in a patient treated by external beams of fast neutrons. International 
Commission on Radiation Units and Measurements, Bethesda, MD, USA. 
Jones D.T.L., Yudelev M. and Hendrikse W.L.J. (1988). Physical characteristics of 
the South African high energy neutron therapy facility. Radiat. Prot. Dosim. 23, 
365-368. 
Jones D.T.L. and Yudelev M. (1988). The effects of various filters on a p(66)/Be 
neutron beam. In: Proceedings of the World Congress on ifedical Physics and 
Biomedical Engineering (J.W. Clark, P.I. Horner, A.R. Smith and K. Strum Eds.) 
Phys. Med. Biol. 33 (Supplement I) pp 133. 
145 
Kellerer A.M. (1971). An assessment of wall effects 1n microdosimetric 
measurements. Radiat. Res. 47, 377-386. 
Kellerer A.M. and Rossi H.H. (1972). The theory of dual radiation action. Curr. 
Top. Radiat. Res. Q. 8, 85-158. 
Kellerer A.M. and Chmelevsky D. (1975). Criteria for the applicability of LET. 
Radiat. Res. 63, 226-234. 
Kellerer A.M. and Rassow J. (1980). The correction for the gamma-ray component 
in neutron therapy Med. Phys. 7 (5), 503-506. 
Kellerer, A.M. (1981). Criteria for the equivalence of spherical and cylindrical 
proportional counters in microdosimetry. Rad. Res. 86, 277-286. 
Kliauga P., Horton J. and Stafford P. (1989). Microdosimetry of a 42 MeV therapy 
beam. Int. J. Radiat. Oncol. Biol. Phys. 16, 845-848. 
Knoll G.F. (1979). Radiation detection and measurement. John Wiley and Sons, 
New York, USA. 
Kritzinger J.J., Fenemore R.E.F. and Van Niekerk M.J. (1991). Performance of the 
NAC RF systems. In: Proceedings of the Twelfth International Conference on 
Cyclotrons and their Applications (B. Martin and K Ziegler Eds.) Springer, Berlin, 
pp 208-211. 
146 
Marquardt D.W. (1963). An algorithm for least-squares estimation of nonlinear 
parameters. J. Soc. Indust. Appl. Math. 11 (2), 431--441. 
Menzel H.H. and Waker A.J. (1976). Gamma dose contributions derived from 
energy deposition spectra. In: Monograph on Basic Physical Data for Neutron 
Dosimetry (J J Broerse, Ed.) CEC, Luxembourg, pp 179-184. 
Menzel H.G. (1984). Proportional counter measurements in neutron beams. In: 
Advances in dosimetry for fast neutrons and heavy charged particles for therapy 
applications. IAEA, Vienna, pp 102-126. 
:Menzel H.G., Buhler G., Schuhmacher H., Muth G., Dietze G. and Guldbakke S. 
(1984). Ionisation distributions and A-150 plastic kerma for neutrons between 13.9 
and 19 MeV measured with a low pressure proportional counter. Phys. Med. Biol. 29 
( 12), 1537-1554. 
Menzel H.G., Pihet P., Folkerts K.H., Dahmen P. and Grillmaier R.E. (1988). 
Dosimetry research using low pressure proportional counters for neutrons with 
energies up to 60 MeV. Radiat. Prot. Dosim. 23, 389-392. 
Menzel H.G., Pihet P. and Wambersie A. (1990). Microdosimetric specification of 
radiation quality in neutron radiation therapy. Int. J. Biol. 57, 865-883. 
Mijnheer B.J., Battermann J.J. and Wambersie A. (1987a). What degree of accuracy 
is required and can be achieved in photon and neutron therapy? Radiother. Oncol. 8, 
237-252. 
147 
Mijnheer B.J., Wootton P., Williams J.R., Eenmaa J. and Parnell C.J. (1987b). 
Uniformity in dosimetry protocols for therapeutic applications of fast neutron beams. 
Med. Phys. 14 (6), 1020-1026. 
Milan J. and Bentley R.E. (1974). The storage and manipulation of radiation dose 
data in a small digital computer. Brit. J. Radial. 47, 113-121. 
Oliver G.D., Quam W.M. and Wilde W.O. (1972). Empirical dose quality 
distributions of californium-252. Health Phys. 22, 341-349. 
O'Neill J. and Laughlin J.S. (1975). A biological determination of the variation of 
fast neutron field quality with depth, RBE and OER. Radiat. Res. 63, 211-225. 
Pihet P., Gueulette J., Menzel II.G., Grillmaier R.E. and Wambersie A. (1988). Use 
of microdosimetric data of clinical relevance in neutron therapy planning. Radiat. 
Proc. Dosim. 23, 471-474. 
Pihet P. (1989). Etude microdismetrique de faisceaux de neutrons de haute energie. 
Applications dosimetriques et radiobiologiques, Thesis (Louvain-la-Neuve: 
Universite Catholique de Louvain). 
Pihet P. and Menzel H.G. (1989). Atomic and molecular data for radiotherapy. 
IAEA-TECDOC-506, Vienna, pp 102-126. 
Pihet P., Menzel H.G., Schmidt R., Beauduin M. and Wambersie A. (1990a). 
Biological weighting function for RBE specification of neutron therapy beams. 
Intercomparison of 9 European centres. Radiat. Prot. Dosim. 31, 437-442. 
148 
Pihet P., Menzel H.G., Wambersie A. and Grillmaier R.E. (1990b). Specification of 
radiation quality for high-LET particle therapy - Microdosimetric approach. In: 
The 2nd European Particle Accelerator Conference (P Marin and M Mandrillon, 
Eds.) Editions Frontieres, France, pp538-539. 
Pihet P., Gerdung S., Grillmaier R.E., Kunz A. and Menzel H.G. (1992a). Critical 
assessment of calibration techniques for low pressure proportional counters used in 
radiation dosimetry. Radiat. Prot. Dosim. 44, 115-120. 
Pihet P., Guldbakke S., Menzel H.G. and Schuhmacher H. (1992b). rvleasurement of 
kerma factors for carbon and A-150 plastic: neutron energies from 13.9 to 20.0 MeV. 
Phys. Med. Biol. 37 ( 10), 1957-1975. 
Pilcher J.V. (1989). Coincident Proton Decay of the Continuum Induced by 200 
MeV Protons on 12c. Ph.D Thesis, University of Cape Town. 
Posny F., Chary J. and Nguyen V.D. (1987). W values for heavy particles in propane 
and in TE gas. Phys. Med. Biol. 32 ( 4), 509-515. 
Randers-Pehrson G., Finlay R.W., Dicello J.F. and McDonald J.C. (1982). A 
technique for time-resolved microdosimetric spectroscopy. In: Proceedings of the 
Eighth Symposium on Microdosimetry (J Booz and HG Ebert, Eds.) CEC, Brussels, 
pp 1169-1177. 
Rassow J., Baumhoer W., Olthoff K., and Bamberg M. (1990). Treatment planning 
for neutron therapy of high-grade astrocytomas and pencil gliomas. Radiother. 
Oncol. 19, 179-185. 
149 
Romero J.L., Brady F.P. and Subramanian T.S. (1985). Neutron induced charged 
particle spectra and kerma from 25 to 60 MeV. Proc. Int. Conf. on Nuclear Data for 
Basic and Applied Science. Gordon and Breach Science Publishers. Santa Fe, New 
Mexico, pp 687-99. 
Rossi R.H. and Rosenzweig W. (1955a). A device for the measurement of dose as a 
function of specific ionization. Radiology 64, 404-411. 
Rossi H.H. and Rosenzweig W. (1955b ). Measurements of neutron close as a function 
of linear energy transfer. Radiat. Res. 2, 417-425. 
Rossi R.H. (1968). Microscopic energy distribution rn irradiated matter. In: 
Radiation dosimetry Volume I, Fundamentals. (F.H. Attix, W.C. Roesch and E. 
Tochilin, Eds.) Academic Press, New York, USA. 
Schmidt R. and Hess A. ( 1988). Component evaluation of event size spectra for a 
clinical 14 MeV neutron beam. Med. Phys. 15 (3), 343-34 7. 
Schrewe U.J., Brede H.J. and Dietze G. (1988a). Investigation of tissue-equivalent 
proportional counters in mixed neutron-photon fields also applyrng time--0f-flight 
techniques. Radiat. Dosim. Prot. 23, 239-213. 
Schrewe U.J., Brede H.J., Pihet P and Menzel H.G. (1988b). On the calibration of 
tissue equivalent proportional counters with built-in a particle sources. Radiat. 
Prot. Dos. 23 249-252. 
150 
Schrewe U.J., Brede H.J. and Dietze G. (1989). Dosimetry in mixed neutron-photon 
fields with tissue-equivalent proportional counters. Radiat. Dosim. Prot. 29, 41--45. 
Schrewe U.J., Brede H.J., Langner F. and Schuhmacher H. (1990). The use of 
rnicrodosimetric detectors combined with time----of-flight techniques. N ucl. Inst. 
Meth. A299, 226-230. 
Schrewe U.J., Brede H.J., Gerdung S., Nolte R., Pihet P., Schmelzbach P. and 
Schuhmacher H. (1992a). Determination of kerma factors of A-150 plastic and 
carbon at neutron energies between 45 and 66 MeV. Radiat. Prot. Dosim. 44, 21-24. 
Schrewe U.J., de Aro A.C.A., Brede H.J., Dangendorf V., DeLuca P.M. Jr., Gerdung 
S., Lim T., Newhauser W., Nolte R., Schmclzbach P., Schuhmacher H. and Scott 
M.C. (1992b). Ionization yield spectra in nitrogen and oxygen for neutron energies of 
17 MeV, 45 MeV and 66 MeV. Presented at The Eleventh Symposium on 
Microdosimetry, 13-18 September, 1992, Gatlinburg, Tenessee, USA. 
Schuhmacher H., Brede H.J., Henneck R., Kunz A., Meulders J.P., Pihet P. and 
Schrewe U.J. (1992). Measurement of neutron kerma factors for carbon and A-150 
plastic at neutron energies of 26.3 and 37.8 MeV. Phys. Med. Biol. 37 (6), 
1265-1281. 
Slabbert J.P., Binns P.J., Jones I--I.L. and Hough J.H. (1989). A quality assessment of 
the effects of a hydrogenous filter on a p(66)Be(40) neutron beam. Brit. J. Radiol. 
62, 989-994. 
151 
Slabbert J.P., Hough J.H., Jones H.L., Schreuder A.N. and Jones D.T.L. (1991). 
Cellular damage in response to variations in the secondary charged-particle spectrum 
of a p(66)/Be neutron beam. National Accelerator Centre Report (NAC/ AR/91-01), 
pp 99. 
Smathers J.B., Otte V.A., Smith A.R., Almond P.R., Attix F.J., Spokas J.J., Quam 
W.M., Goodman L.F. (1977). Composition of Al50 tissue equivalent plastic. Med. 
Phys. 4, 74-77. 
Srdoc D. (1970). Experimental technique of measurement of microscopic energy 
distribution in irradiated matter using Rossi counters. Radiat. Res. 43, 302-319. 
Stafford P., Horton J.L. and Almond P.R. (1987). A microdosimetric 
characterization of a cyclotron-produced therapeutic neutron beam. Med. Phys. 14, 
1015-1019. 
Stinchcomb T.G., Kuehner F.T. and Skaggs L.S. (1980). Comparison of the 
microdosimetric event size-method and twin-chamber method of separating dose 
into neutron and gamma components. Phys. Med. Biol. 25, 51-64. 
Stinchcomb T.G., Kuchnir F.T., Myrianthopoulos L.C., Horton J.L. and Roberts 
W.K. (1986). Correlation of microdosimetric measurements with relative biological 
effectiveness from clinical experience for two neutron therapy beams. Med. Phys. 13, 
201-206. 
Stone R.S. (1948). Neutron therapy and specific ionization. Am. J. Roentgol. 59, 
771-785. 
152 
Svensson H. ( 1984). Quality assurance in radiation therapy: Physical Aspects. Int. 
J. Radiat. Oncol. Biol. Phys. 10, (Suppl.) 59--65. 
Taylor G.C., Scott M.C. and Fletcher J.G. (1990). Microdosimetric measurements 
on the Clatterbridge neutron cancer therapy cyclotron. Radiat. Prot. Dosim. 31, 
443-447. 
Vynckier S., Vanneste F., Richard F. and Wambersie A. (1988). Treatment planning 
for neutron therapy. Radiat. Proc. Dosim. 23, 463-469. 
Waibel E. and Willems G. (1987). Stopping power and ranges of low--€nergy protons 
in tissue--€quivalent gas. Phys. Med. Biol. 32 (3), 365-370. 
Waker A.J. ( 1985). Experimental uncertainties rn microdosimetric measurements 
and an examination of the performance of three commercially produced proportional 
counters. Nucl. Instru. and Meth. A234, 354-360. 
Wambersie A. and Gueulette J. (1984). Accuracy required in radiotherapy and in 
neutron therapy. In: Advances in dosimetry for neutrons and heavy charged particles 
for therapy applications, Vienna 1982. IAEA, Vienna, pp 11-26. 
Wambersie A. and Battermann J.J.(1987). Practical problems related to RBE in 
neutron therapy. In: Progress in Radio-Oncology III (K.H.Karcher, H.D. Kogelnik 
and T. Szeipesi, Eds.) Vienna, ICRO, pp 155-162. 
Wambersie A. (1990). Fast neutron therapy at the end of 1988 - a summary of 
clinical data. Strahlenther. Onkol. 166, 52--60. 
153 
Wambersie A and Mijnheer B.J. (1990). Expression of dose rn neutron therapy. 
Radiother. Oncol. 17, 261-266 
Wambersie A., Pihet P. and Menzel H.G. (1990). The role of microdosimetry rn 
radiotherapy. Radiat. Proc. Dosim. 31, 421-432. 
Weaver K., Bichsel H., Eenmaa J. and Wootton P. (1977). Measurement of photon 
dose fraction in a neutron radiotherapy beam. Med. Phys. 4, 379-386. 
White R.M., Broerse J.J., DeLuca P.M. Jr., Dietze G., Haight R.C., Kawashima K., 
Menzel H.G., Olsson N. and Wambersie A. (1992). Status of nuclear data for use in 
neutron therapy. Radiat. Prot. Dosim. 44, 11-20. 
Wuu C.S. and Milavickas L.R. (1987). Determination of the kerma factors in 
tissue--€quivalent plastic, C, M and Fe for 14.7 MeV neutrons. Med. Phys. 14 (6), 
1007-1014. 
Zeitz L., Canada T.R., Djordjevic B., Dymbort G, Freeman R, McDonald J.C., 
O'Neill J. and Laughlin J.S. (1975). A biological determination of the variation of 
fast neutron field quality with depth, RBE and OER. Radiat. Res. 63, 211-225. 
